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The ubiquitin-proteasome system plays an essential role in the biology of 
eukaryotes. Through turnover of short-lived proteins, it regulates vital processes such as 
cell cycle progression, transcription, misfolded-protein degradation, and immune 
response. One scenario of how ubiquitinated proteins are driven to the 26S proteasome 
for degradation involves shuttle proteins (Rad23, Dsk2, or Ddi1), which recognize their 
substrate through a ubiquitin associated (UBA) domain and identify the proteasome 
through their ubiquitin like (UBL) domain. 
Ddi1 (DNA Damage-Inducible 1) protein has an unusual composition for a 
UBL-UBA protein as it also contains a conserved retroviral protease fold domain 
(RVP). The detailed substrate specificity of Ddi1 as a shuttle is not known; however, it 
was found that Ddi1 is required for degradation of Ho endonuclease and F-box protein 
Ufo1, two proteins involved in cell cycle progression and regulation. In Saccharomyces 
cerevisiae, both UBA and UBL domains of Ddi1 are required for its shuttling function. 
Interestingly, through evolution, Ddi1 lost its UBA domain in mammals, which raises 
the question of how this shuttle protein performs its function without the domain that 
binds Ub. Furthermore, the presence of a UBL domain is also questionable since the N-
terminal gene sequence of Ddi1 in yeast shares low identity with Ub and other known 
UBL domains. In order to fully confirm that yeast Ddi1 is an UBL-UBA shuttle, the 
solution structure of the nominal UBL domain was obtained. In addition, the functional 
properties of UBL domains were examined. This work shows that Ddi1UBL does not 
recognize its expected binding partners, one example being the ubiquitin interactive 
motif (UIM) domains of the Ufo1 protein. However, it is capable of recognizing 
ubiquitin (Ub) and its conjugates as well as the UBL domain of Dsk2, which is a novel 
interaction and is uncharacteristic for all known UBL domains. 
To date, UBL-UBA shuttle proteins are well-studied proteins in the ubiquitin 
proteasomal pathway. Nevertheless, the details of target protein delivery to the 
proteasome for degradation are not well known. This work characterizes Ddi1 as an 
UBL-UBA protein, confirming its potential as a shuttle protein like other UBL-UBA 
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Chapter 1. Introduction and specific aims 
1.1 The ubiquitin proteasome system 
The ubiquitin proteasome system (UPS) is responsible for turnover of short-
lived proteins by the 26S proteasome. The UPS mechanism for protein degradation 
plays a very important role in cellular regulation in eukaryotes, as it influences a variety 
of essential cellular pathways such as: cell cycle progression, transcription, misfolded 
proteins degradation, DNA repair, and the immune and stress response (Figure 1-1)1-11. 
Dysfunction of the UPS leads to the failures in cellular pathways, and as a consequence, 
to number of severe inflammatory diseases, cancer and neurological disorders6,12-16. 
 





In the ubiquitin proteasome system, the protein of interest is modified with a 
signaling protein called ubiquitin (Ub). With the use of three enzymes, E1 (ubiquitin 
activating enzyme), E2 (ubiquitin conjugating enzyme) and E3 (ubiquitin protein 
ligase), Ub is attached to the target protein of interest. Depending on the final signaling 
pathway, the ubiquitinated protein can be mono-, multi- or polyubiquitinated (Figure 1-
2). 
 
Figure 1-2. Mono-/multi-/poly-ubiquitination schemes. In Eukaryotes, the mode of 
ubiquitination influences which signaling pathway target protein are delivered to. 
 
In S.cerevisiae, target proteins that are polyubiquitinated for 26S proteasomal 
degradation are either directly recognized by the intrinsic receptors: Rpn10 and Rpn13, 
that are part of 19S proteasomal subunit, or by the shuttle proteins: Rad23, Dsk2 and 




substrates can be recognized by just one or both of the pathways simultaneously, which 
is supported by the discovery that the function of Ub receptors is redundant, and only 
concurrent deletion of two or more cause accumulation of ubiquitinated proteins26,28-31.  
 
Figure 1-3. Delivery of polyubiquitinated proteins for proteasomal degradation. 
Target proteins can be directly recognized by the proteasome (Rpn10, Rpn13) or 
by shuttle proteins (Rad23, Dsk2, Ddi1) that will deliver target proteins to the 26S 
proteasome by binding to it. 
 
Shuttle proteins such as Rad23, Dsk2, and Ddi1 are a group of proteins that have 
a Ubiquitin Like Domain (UBL) on their N-terminus and Ubiquitin Association Domain 
(UBA) on the C-terminus. Ddi1 and Dsk2 have just one UBA domain while Rad23 has 
two, a UBA1 that follows the UBL domain and a UBA2 domain at the C-terminal end 
(Figure 1-4). It has been hypothesized that UBL-UBA proteins perform their shuttle 
function by utilizing their UBL domains to interact with the proteasome, and their UBA 






Figure 1-4. Schematic representation of the gene structure of S.cerevisiae shuttle 
proteins: Ddi1, Rad23, and Dsk2. Abbreviation annotation: UBL, Ubiquitin Like 
Domain; RVP, retroviral protease fold domain; UBA, Ubiquitin Association 
Domain; STI, stress-inducible-1. 
 
1.2 Ubiquitin and ubiquitination 
Ubiquitin is highly conserved among eukaryotic species. It consists of 76 amino 
acids with molecular mass of 8.5kDa. On the Ub surface there is a hydrophobic patch 
composed of the side chains from the amino acids L8, I44 and V70 that interact with Ub 
receptors (Figure 1-5)36-38. In the sequence there are also seven conserved lysines: K6, 
K11, K27, K29, K33, K48, and K63. Also present is a –GG motif (G75,G76) on the C-





Figure 1-5. Ribbon representation of Ub structure. Amino acids comprising the 
hydrophobic patch are shown as grey spheres. All conserved lysines are shown as 
dark grey sticks. –GG motif is shown as grey sticks. Ub structure was obtained 
from 1ubq.pdb. 
 
Upon postranslational modification, a Ub molecule is covalently attached to the 
lysine side chain of the substrate protein. The amino group of this side chain forms an 
isopeptide bond with the carboxylic group of the carboxyl-termnal amino acid (G76) in 





Figure 1-6. Isopeptide bond between Ub and substrate/Ub. Isopeptide bond is 
shown in red. Top figure shows the bond formed between Ub Gly 76 and the amino 
group of the Lys side chain from the substrate protein. The lower figure shows the 
isopeptide bond between two Ub molecules. 
 
As mentioned above, ubiquitination is achieved by a cascade of multienzymatic 
reactions (Figure 1-7), which can be described by the following steps: 
– Activation of Ub by the E1 enzyme. E1, with the use of ATP, synthesizes a 
Ub C-terminal adenylate, which as an enzyme bound substrate is used to 
form an E1-ubiquitin thiol ester bond. 
– Transfer of Ub from E1 to the active site cysteine of an E2 enzyme. E2 
enzymes are also called ubiquitin-conjugating (UBCs) or ubiquitin-carrier 




– Transfer of activated Ub from E2 to a substrate-specific E3 enzyme. E3 is a 
ubiquitin-protein ligase that binds substrate protein and E2 enzyme. The 
isopeptide bond between the C-terminal glycine residue of Ub and the lysine 
residue of the target protein is created.  
After this cascade of events the monoubiquitinated protein is created. To form 
the polyubiquitinated protein, the above steps are repeated, with the only difference 
being that the lysine of the previously bound Ub is used to create an isopeptide bond 
with the successive Ub protein.  
 
Figure 1-7. Ubiquitination pathway. Initially Ub is activated by E1 enzyme and 
then transferred to E2 enzyme. The specific substrate is recognized by the E3 
ligase. In the last step, Ub is covalently linked to a lysine residue of the target 
protein, where an isopeptide bond is created. The process is repeated if the target 




In the case of poly-ubiquitination, Ub molecules are attached through either each 
of the seven lysines, or the free amino group at the N-terminus, which leads to various 
linkage chain formations. The Ub unit which has a free C-terminal end is referred to as 
“proximal”, while the Ub molecule which provides the C-terminus for isopeptide bond 
formation is called “distal”. It was previously shown that different linkages dictate 
diverse conformations of polyUb chains and as a result different orientations of the 
hydrophobic patches39.  
It was shown that in the structure of K48-linked dimer (K48-Ub2) hydrophobic 
patches of both Ub units are in a closed conformation, indicating that the  patches 
interact with each other to form a hydrophobic interface (Figure1-8)40. Meanwhile, the 
K63-linked dimer (K63-Ub2) has an open conformation with both hydrophobic patches 






Figure 1-8. Structure comparison of K48-Ub2 and K63-Ub2. Each of the chains has 
a different conformation. Hydrophobic patch for each Ub unit is shown as grey 
spheres. Isopeptide bond is shown in magenta. K48-Ub2 structure was obtained 
from pdb with access number 2BGF, while K63-Ub2 access number is 2RR9. 
 
Different orientations of hydrophobic patches dictate differences in recognition 
of Ub receptors. For example, the UBA2 domain of the Rad23 human isoform 
(hHR23a) binds K48-Ub2 in a sandwich mode, where UBA2 interacts with both 
hydrophobic patches simultaneously. In the case of K63-Ub2 each hydrophobic patch 





Figure 1-9. Different binding modes of UBA2 and Ub2 chains. UBA2 (dark cyan) 
domain from hHR23A receptor. K48-Ub2 (orange, top panel) binds one UBA2 
domain in sandwich like mode (1ZO6) and K63-Ub2 (orange, bottom panel) binds 
two UBA2 domains (source R.Varadan/D.Fushman). The hydrophobic patches are 
shown as gray spheres; isopeptide bond is shown in magenta.  
 
Dissimilarity in the type of linkage also dictates to which signaling pathway the 
ubiquitinated protein will be targeted. It was shown that polyubiquitin chains linked 
through K48 and K11 are responsible for targeting proteins for proteasomal 





1.3 E1, E2, E3 enzymes 
1.3.1 Hierarchical system of ubiquitination enzymes specificity 
The possibility of creating polyUb chains through different lysine residues is 
strongly related to the type and role of the target protein. A hierarchical system can be 
proposed to explain the substrate specificity of particular enzymes involved in the 
ubiquitination process (Figure 1-10).  
A single E1 enzyme activates Ub, which is transferred to several E2 enzymes. 
E2 can then transfer Ub to a particular E3 or to a subclass of numerous E3 enzymes. E3 
is responsible for the target protein selection and specificity. It can be dedicated just to 





Figure 1-10. Hierarchical scheme of the enzymes involved in ubiquitination. E1 
enzyme activates ubiquitin for all E2 enzymes and E3s. E2 enzymes are E3 
specific, whereas E3s are substrate specific. 
 
1.3.2 SCFUfo1 - E3 ligase enzymes 
A few families of E3 ubiquitin-ligase enzymes have been characterized. One is 
the SCFs (Skp1-Cdc53/Cull-F-box protein), a class of E3 ligase proteins involved in 
cell cycle regulation. SCFs are comprised of common subunits as well as individual 
proteins that define substrate specificity52. In the SCF complex, the C-terminal domain 
of Cdc53/Cul1 binds the Rbx1 protein that interacts with the E2 enzyme. The N-




Skp1 adaptor is responsible for F-box protein recognition and binding, while F-box 
proteins define substrate specificity, and by binding to Skp1, they bring the substrate 
and E2 enzyme into close proximity53. 
 
Figure 1-11. Scheme architecture of the SCF E3 ligase with Ufo1 as F-box protein. 
 
F-box proteins are a group of proteins that mediate protein-protein interactions. 
Ufo1 is an unusual F-box protein among the SCF complex because it not only has a 
protein-protein interaction domain but also contains three copies of the ubiquitin-
interacting motif (UIM). UIM is a motif that has a series of hydrophobic residues 
LALAL or LAMAL, which are terminated by the conserved Ser amino acid. 
Transcription of Ufo1 begins in response to DNA damage54,55. Ufo1 as well as other F-
box proteins are short-lived proteins that undergo ubiquitination. Molecular biology 
studies propose that there is a specific interaction between the Ddi1 UBL domain, and 
Ufo1 UIM56. Moreover, this interaction seems to be essential for the turnover of the 
SCFUfo1 complex (SCF complex with Ufo1 as a F-box protein) and plays a role in cell 




1.4 DNA Damage Inducible protein, Ddi1 
1.4.1 UBL-UBA protein Ddi1 and its evolution 
The Ddi1 (DNA Damage-Inducible 1) protein was first discovered in 1997 and 
was characterized as a gene whose transcription was induced in response to a variety of 
stress factors in yeast57. The composition of the shuttle protein Ddi1 from S.cerevisiae 
is unusual. In addition to a UBL and a UBA domain, between these domains it contains 
a conserved retroviral protease fold domain (RVP), followed by a putative PEST region 
and Sso1-binding domains (Sso1-BD) (Figure 1-12)58,59. 
 
Figure 1-12. Schematic representation of the Ddi1 gene structure from S.cerevisiae. 
 
The N-terminal UBL domain of Ddi1 (Ddi1UBL) has 19.8% and 11.0% 
sequence identity with Rad23 and Dsk2, respectively. The sequence identity with yeast 
Ub homolog is only 18.4% (19.5% for human Ub), compared to 23% sequence identity 






Figure 1-13. Sequence alignments of the Ddi1UBL domain with Ub (yeast and 
human homolog), Rad23UBL and Dsk2UBL. Lines (dark grey shading) indicate 
identity; colons (grey shading) indicate similarity in the sequence and dots indicate 
small similarity. The EMBOSS program was used to align the sequences60. 
 
The C-terminal UBA domain of Ddi1 (Ddi1UBA) has 29.3% sequence identity 
with the Rad23 UBA1 domain, 39.5% sequence identity with the Rad23 UBA2 domain 






Figure 1-14. Individual sequence comparison of Ddi1UBA domain with UBA 
domains of Rad23 and Dsk2. Lines (dark grey shading) indicate identity; colons 
(grey shading) indicate similarity in the sequence and dots indicate small 
similarity. The EMBOSS program was used to align the sequences60. 
 
Sequence alignment of the UBL domains and Ub with each other, as well as 
alignment of the UBA domains, indicates conserved residues (Figure 1-15). In the case 
of the UBL domain of Ddi1, these residues are: Leu45, Leu52 and Thr57. For UBA 
domain, these are: Gly402, Ala422, and Leu426 (residue numbering is with respect to 
the full length Ddi1 sequence).  
Interestingly the analysis of Ddi1 gene conservation among different species 
shows that, with just one exception, the UBL domain is always present in the Ddi1 






Figure 1-15. Sequence alignment of the Ddi1UBA and Ddi1UBL with the UBA and 
UBL domains of other shuttle proteins (Dsk2 and Rad23). Top panel, sequence 
alignment of the Ddi1UBA domain with Dsk2 and Rad23 UBA domains. Bottom 
panel, Ddi1UBL alignment with Ub (yeast and human homolog) and Rad23UBL 
and Dsk2UBL. Dark grey shading indicates identity; grey shading indicates 






Figure 1-16. Ddi1 gene structure among different eukaryotes. (a) Domain 
representation for several eukaryotic organisms; UBL – ubiquitin like domain, 
RVP – retroviral protease-like domain, UBA – ubiquitin association domain, 
shown as solid blocks. The dashed block indicates the potential presence of an C-
terminal sequence that was identified by the domain prediction software but did 






1.4.2 Putative function of Ddi1 UBL and UBA domains. 
The detailed roles of the both UBL and UBA domains of Ddi1 are not known. 
However, a few processes in which these domains are involved have been discovered. 
Dimerization of shuttle proteins. The UBL-UBA proteins Ddi1, Rad23 and 
Dsk2 are known to have the ability to homodimerize. The Rad23 and Dsk2 proteins 
require UBA domains for their dimerization, while Ddi1 mediates it through the RVP 
domain61,62. Additionally, it was observed that Rad23 can heterodimerize with both 
Ddi1 and Dsk229,62. The UBA domain of Rad23 is essential for Rad23-Dsk2 interaction, 
but it is not known which domain of Dsk2 is involved in this heterodimerization29. Two 
models have been proposed for Rad23 and Ddi1 dimerization. The first one suggests 
that both proteins utilize their UBA domains (UBA1 of Rad23 and UBA of Ddi1)61. On 
the contrary, according to the second model the UBA domain of Ddi1 and the UBL 
domain of Rad23 are responsible for this heterodimerization30.  
Ddi1 UBL-UBA potential binding partners. UBA and UBL Ddi1 domains are 
not only involved in dimerization, but also in interactions with other binding partners. 
As mentioned previously, it was shown that the UBL domain of Ddi1 interacts with the 
F-box protein Ufo1 most probably through its UIM domain, yet unfortunately no 
biochemical parameters are known for this interaction56. Furthermore, it was shown that 
the Ddi1 UBL domain also binds the 19S regulatory subunit of the proteasome23. 
Interestingly, in other studies it was discovered that the hHR23A UBL domain binds to 
the human homolog Rpn1063. Therefore, Rpn10 might be a potential binding partner for 




Additionally, the regulation of the Pds1 protein depends on the presence of the 
Ddi1 protein. Pds1 inhibits cell cycle progression to the anaphase in S.cerevisiae. 
Deletion of Ddi1 and Rad23 genes rescues the temperature stability of Pds1. It is 
proposed that the binding between Ub moieties of ubiquitinated Pds1 and the UBA 
domain of Ddi1 prevents the polyUb chain from elongation17. Another role of the Ddi1 
UBA domain was revealed in degradation of Ho endonuclease, the substrate for the 
SCFUfo1 ligase23. Ho endonuclease function is highly regulated: after performing its role 
in initiation of mating type interconversion it is recruited by Ufo1 to the SCF ubiquitin 
ligase complex for ubiquitination and subsequently degraded by the 26S 
proteasome23,64,65. The absence of the Ddi1 stabilizes the Ho endonuclease. As the 
ubiquitination of Ho endonuclease is required for degradation, it was proposed that the 
Ddi1UBA domain interacts with the Ub moieties.  
The change in the role of Ddi1 from supporting degradation, as in the case of Ho 
endonuclease to preventing polyUb chain from elongation is not fully understood. It 
might be due to the fact that in both processes different E3 complexes are involved. 
Pds1 is ubiquitinated by the APC E3 ligase, while Ho endonuclease by SCFUfo1 
complex17,23. The  Pds1 stability regulation depends on the presence of both Ddi1 and 
Rad23 which may also indicate that the process of heterodimerization is involved in this 
phenomenon17. Despite the differences in both cases, it was the Ddi1UBA that was 
necessary for interaction with Ub moieties. Indeed, other studies show that the UBA 
domain of Ddi1 binds monoUb as well as polyUb chains32. Full length Ddi1 has a Kd 
for monoUb around 10 µM unfortunately no Kd value is known for polyUb chains32. 




heterodimerization with shuttle proteins or by interactions involving the UBL domain. 
Kang et.al 2006 made an attempt to study the effect of Ub binding upon dimerization, 
however the results do not give a clear answer30.  
1.5 Research motivation and specific aims. 
As emphasized above, the ubiquitin proteasome system plays a very crucial role 
in eukaryotes. In particular, it is very important to understand how shuttle proteins 
deliver polyubiquitinated proteins for proteasomal degradation. While Rad23 and Dsk2 
have been pretty extensively characterized, information about Ddi1 is lacking. Some 
partial knowledge about its role in the cell is available from molecular biology studies; 
however the detailed functions of Ddi1 are not known. So far, it was shown that Ddi1 is 
a multi-domain protein and particularly that the UBL and UBA domains play an 
important part in the proteasomal degradation pathway. Furthermore, due to very low 
sequence identity between Ddi1 and Ub, as well as other UBL domains of shuttle 
proteins, it is unclear whether Ddi1 indeed contains a UBL domain and what its binding 
preferences are. Additionally, analysis of domain conservation among different species 
indicates that, with just one exception, the UBL domain is always present in Ddi1 
sequence, while the UBA domain is not present in mammals. This loss of the UBA 
domain during evolution might be a result of its lack of functional importance in higher 
organisms, which then raises the question, of whether and how Ddi1 can act as a shuttle 
protein without a Ub-binding component. Finally, no RVP-domain activity as a protease 
was tested before in the context of the ubiquitin-proteasome system. In order to 




and functional characterization of this multi-domain protein. Structural studies 
confirmed the expected fold of the Ddi1UBL domain. Surprisingly, the first 
experiments for functional characterization of Ddi1 disclosed many unexpected 
properties of this protein. 
Aims: 
1. Structural studies of Ddi1UBL 
The N-terminal domain of Ddi1UBL shares low sequence identity with ubiquitin 
and other UBL domains of shuttle proteins. Since the presence of the UBL domain in 
Ddi1 was only predicted through bioinformatics the first goal of the presented work was 
to test whether Ddi1 indeed has a domain that has a Ub fold. Having confirmed the 
relevance of studying individual Ddi1UBL, a series of spectra were collected in order to 
obtain full 1H, 13C and 15N resonance assignment. This assignment was used further to 
obtain structural and distance constraints that allowed for three dimensional structure 
calculations. 
2. Ddi1 – novel ubiquitin receptor 
Ddi1 is a multi-domain protein; in this study we addressed the properties and 
functions of the previously uncharacterized RVP and UBL domains in the context of 
UPS system. It is already known that through its UBA domain Ddi1 interacts with Ub. 
Surprisingly, while monitoring UBA-Ub interaction in the Ddi1FL construct, we 
discovered that the UBL domain of Ddi1 also interacts with Ub. Interaction of any UBL 
domain and Ub has not been previously observed. Results presented here characterize 
the unique discovery and deliver information on affinity between Ddi1UBL and Ub, 




the Ddi1UBL interaction with its known binding partner, UIM domains from Ufo1 
protein, for which activity was also tested against Ub. 
3. Ddi1UBL, first known ubiquitin like domain with UIM motif 
Also of interest was determining whether Ub was the only unusual binding 
partner of Ddi1UBL. Since shuttle proteins can heterodimerize, we wanted to determine 
if Ddi1 utilizes its UBL domain to form such interaction. These studies led to the 
discovery that Ddi1UBL binds to the UBL domain of Dsk2 and the mode of its binding 
differs from the one with Ub. Detailed analysis revealed that Ddi1UBL appears to have 
two binding sites for Dsk2UBL and the second one involves an α-helix. Interestingly, 
this second binding site is also used for distinguishing between binding monoUb and 
Ub dimers. Finally the focus of the studies was to understand what is special about the 





Chapter 2. Structural studies of Ddi1UBL 
2.1 Ddi1 domains can be studied independently 
As mentioned above, it is believed that Ddi1 belongs to the UBL-UBA shuttle 
protein family. Such classification comes from the fact that the N- and C-terminal 
fragments of the Ddi1 gene were identified bioinformatically as the UBL and UBA 
domains, respectively17,61. First, it was essential to confirm that the spectral/structural 
properties of the isolated N- and C-terminal Ddi1 fragments (containing the putative 
UBL and UBA domains) are the same as in the context of the full-length (FL) Ddi1 
construct.  
For this purpose, 2D 1H-15N TROSY spectrum of FL Ddi1 was recorded and 
compared with the corresponding spectra of the isolated fragments. The majority of 
NMR signals overlaid almost perfectly, indicating that the chemical environment for 
each amide group is essentially the same in the FL protein and in the isolated fragments 
(Figure 2-1). Small discrepancies can be observed only for a few C-terminal residues in 
Ddi1UBL and are not unexpected, as they reflect a change in the chemical environment 
as a result of the truncation. Similarly, for the first few residues of the UBA domain, the 
lack of preceding amino acids that are present in the full-length construct explains the 





Figure 2-1. 1H-15N TROSY spectra of the full length Ddi1. 1H-15N TROSY spectra 
of the full length Ddi1 (red) overlaid with the spectra of the isolated fragments 
containing only UBA (blue) and UBL (green) domains; spectra of individual 
domains are shown in boxes with the same color coding. 
 
Furthermore, because the Ddi1UBA construct is quite short (44 a.a.), even small 
changes at its N-terminus may affect other residues that are close in space. This 
explains some small changes in peak positions observed for the rest of the Ddi1UBA 
signals. It is noteworthy that the UBA and UBL signals in the spectrum of the FL Ddi1 
(a 47 kDa protein) are relatively sharp, which indicates that both domains tumble 




further confirmed by analysis of the 15N longitudinal relaxation time (T1) which 
depends on the overall tumbling rate, and hence contains information about the size of 
the molecule42. Especially in the case of Ddi1UBL, the general pattern of 15N T1 values 
is retained and the overall levels of T1 are quite similar for the isolated domain and in 
the FL protein (Figure 2-2). This indicates that in both cases the UBL domain tumbles 
in the same manner and is not affected by the rest of the FL Ddi1 protein.  














Figure 2-2. Comparison of 15N T1 relaxation rates for the Ddi1UBL and UBL 
domain of Ddi1FL. 15N T1 relaxation rates for the UBL domain of Ddi1UBL are 
shown in blue, for the Ddi1 full length construct are shown in red. For the full-
length construct, only data for residues assigned with confidence are shown. The 





2.2 Sequential assignment 
In order to obtain the three dimensional structure of a protein by means of NMR 
it is necessary to assign resonance frequencies of proton, nitrogen and carbon atoms in 
the protein. Unfortunately, only protons (1H) have nonzero spin whose interactions with 
magnetic field can be monitored by NMR. The most abundant isotopes of carbon (12C) 
and nitrogen (14N) present in biological samples have zero spin and therefore are 
invisible for NMR spectroscopy. In order to record resonance frequencies of nitrogen 
and carbon atoms, the protein sample is enriched during preparation with NMR active 
isotopes such as 13C and 15N. A double labeled Ddi1sample (13C,15NDdi1UBL) was used 
to measure 3D triple resonance experiments such as: HNCO, HN(CA)CO, HN(CO)CA, 
HNCA, CBCA(CO)NH, HNCACB. These experiments allowed for basic assignments 
of HN, N, C', Cα, Cβ carbon atoms that are present in amino acids. The design of 
experiments also allows for linking resonances of particular residues (i) to carbons in 
preceding amino acids (i-1). This particular feature allows for linking amino acids 
resonances together, indicating which resonance belongs to which amino acid within the 
sequence. This so called sequential assignment is essential for protein structure 
calculation. The detailed resonance patterns that can be observed in the above 









Experiment name Resonances observed 
HNCO i-1C’ ← iHN 
HN(CA)CO i-1C’  ← iHN →  iC’ 
HN(CO)CA i-1Cα ← iHN 
HNCA i-1Cα ← iHN →  iCα 
CBCA(CO)NH i-1Cβ,i-1Cα →  iHN 
HNCACB i-1Cβ,i-1Cα ← iHN →  iCα, iCβ 
CC(CO)NH i-1Cε,i-1Cδ,i-1Cγ,i-1Cβ,i-1Cα →  iHN 
H(CCO)HN i-1Hε,i-1Hδ,i-1Hγ,i-1Hβ,i-1Hα →  iHN 
 
Table 2-A. Summary of resonance assignments obtained from triple resonance 
experiments. 
 
Having initial assignments for C’, Cα, Cβ of individual amino acids, CC(CO)NH, 
H(CCO)HN triple resonance experiments were analyzed in order to obtain the 
remaining carbon and proton side chain assignments. These two spectra show the 
“towers” of carbons/protons (respectively) of a particular residue being linked to an 
amide group of a preceding amino acid. Overall, this analysis allowed almost full 
assignment for carbons and protons present in the amino acid side chains. The complete 
proton assignment was confirmed by analysis of 2D and 3D TOCSY spectra that also 
show proton towers that are linked to its own amide resonances. Finally, the sequential 
assignment was verified by 2D and 3D NOESY experiments. The entire sequential 




2.3 Structural constraints 
The sequential assignment is essential, but not sufficient for structure 
calculation. In order to obtain high resolution NMR protein structure, a number of 
constraints that deliver information on the distance between atoms and bonds geometry 
is required. 
2.3.1 NOE constraints 
The main parameters used for structure calculations are dipolar cross-relaxation 
(NOE) rate constants that arise from the fact that dipolar-coupled spins do not relax 
independently. With some approximation, the intensity of the NOE peak is proportional 
to the inverse sixth power of the distance between two interacting 1H spins:  
                                                NOE ∝ 1/r6               (1) 
The NOE cross-peaks that are observed in 2D and 3D NOESY experiments 
allow detecting cross-peaks of atoms that are separated by up to 5.5Å distance in space. 
Depending whether the atoms belong to the same amino acid (i-i) or two different 
residues (i-j), the NOE constraints can be divided into two groups: intra- and inter 
residue. Furthermore, the inter-residue NOEs can be divided into three categories based 
on the proximity of amino acids with atoms that cause the cross-peak: 
– sequential, i and j are neighboring residues; 
– medium, i and j are less than four amino acids apart; 
– long-range, cross-peak is between atoms of residues that are more than 4 amino 




The amount and type of NOEs distances used for Ddi1UBL structure 
calculations can be found in Table 2-B. 
 
 DISTANCE CONSTRAINTS STATISTICS 
Total NOEs 1101 
   Intra-residue 431 
   Inter-residue 670 
      Sequential (|i – j| = 1) 296 
      Medium-range (|i – j| < 4) 141 
      Long-range (|i – j| > 4) 233 
 
Table 2-B. NMR unique NOE distance statistics for Ddi1UBL structure. 
 
Despite the fact that both 2D and 3D NOESY experiments were used for NOE 
assignment, the 2D NOESY experiment was used to prepare the list of unique (above 
the diagonal) distance constrains in the format of *.peaks file. The cross-peak intensities 
were obtained with use of the CARA Integration Tool that allows for tuning of the 
peak’s base width and model66. Integration was performed with the Model-Based Linear 
Equation System. The list of NOEs was checked against unrealistic intensities that 
occasionally arise from peak overlaps and result in mistaken values during linear 




2.3.2 Dihedral angle constraints 
The polypeptide backbone is sterically constrained by torsion angles (dihedral 
angles): Phi (Φ, around the Cα-N bond) and PSI (Ψ, around the Cα-C’ bond). The 
torsion angles between peptide groups describe polypeptide chain conformations and 
define the geometric properties of peptide groups. The restrictions put on the allowed 
dihedral angles are summarized in a Ramachandran plot, which helps easily identify 
forbidden conformations of polypeptide chains. Interestingly, Φ and Ψ angle values also 
help identify secondary structure elements since amino acids that are part of a particular 
secondary structure will show sequences of repeating torsion angle values.  
As emphasized above, dihedral angles are a set of very important constraints for 
structure calculation. Fortunately, information about dihedral angles can be predicted 
based on secondary chemical shifts: differences between observed chemical shifts and 
chemical shifts for the same amino acid but in the random coil. The software TALOS+ 
is a useful tool that allows prediction of torsion angles based on secondary chemical 
shifts for the following nuclei: 1HN, 1Hα, 13Cα, 13Cβ, 13C’, and 15N, along with 
information about the protein sequence. Prediction is based on triplets of amino acids 
and the goal is to match all measured secondary shifts to secondary shifts of triplets that 
are available in the database. A good prediction is made when 10 different matches 
from the database give consensus secondary shift values for each amino acid within the 
triplet. The dihedral angles for triplets in database are known and therefore torsion 






TALOS+ predicted dihedral angels for the majority of amino acids in the 
Ddi1UBL sequence (Table 2-C). It can be easily noticed that based on prediction amino 
acids at the C-terminal end of Ddi1UBL show some dynamics, and it is therefore 
impossible to predict PSI and PHI angles. Even though a number of amino acids show 
ambiguous values (shown in yellow), it is worth mentioning that the majority had 9 out 
of 10 good matches. A total of 63 PSI and PHI angles that can be trusted were used as 
one of input files for structure calculation.   
 
TALOS+ Ddi1UBL 
M1 D2 L3 T4 I5 S6 N7 E8 L9 T10 
G11 E12 I13 Y14 G15 P16 I17 E18 V19 S20 
E21 D22 M23 A24 L25 T26 D27 L28 I29 A30 
L31 L32 Q33 A34 D35 C36 G37 F38 D39 K40 
T41 K42 H43 D44 L45 Y46 Y47 N48 M49 D50 
I51 L52 D53 S54 N55 R56 T57 Q58 S59 L60 
K61 E62 L63 G64 L65 K66 T67 D68 D69 L70 
L71 T72 I73 R74 G75 K76 I77 S78 N79 S80 
K81 L82 N83  
 
Table 2-C. Ddi1UBL sequence in TALOS+. Each residue has a specific color based 
on the software classification. Green - unambiguous/good prediction, Yellow - 
ambiguous/no prediction, Blue - dynamic/no prediction, Red - bad prediction 
relative to a known structure, Gray - no classification. 
 
2.3.3 Secondary structure prediction 
Information from chemical shifts of backbone atoms can be also used for 




13C’, 13Cα and 13Cβ backbone nuclei show dependence on secondary structures. It is well 
established that secondary chemical shifts have characteristic values that can be 
correlated to particular secondary structure elements67-69. This phenomenon is used for 
example in the chemical shift index method (CSI) that allows for identification of 
secondary structures70,71. Taking advantage of this well established approach, the 1Hα, 
13C’, 13Cα and 13Cβ chemical shifts from Ddi1 assignment were used to predict 
secondary structure elements (Figure 2-3).  
The CSI method is not the only method that allows for secondary structure 
prediction. Talos+ is another program that allows for such analysis. In this approach 
1Hα, 13C’, 13Cα and 13Cβ and 15N chemical shifts of Ddi1UBL were used for 
identification of secondary structure elements.  In addition to predicting secondary 
structures, Talos+ predicts order parameters (S2) based on the random coil index (RCI) 
method72. Order parameters help identify regions that are dynamically disordered and 
recognize complementary information required for predication of secondary structure 
elements. S2 values vary from 0 to 1, where 1 will correspond to most structured 
elements and S2 values smaller than 0.5 will belong to dynamic elements. 
Both CSI and Talos+ identified similar regions in Ddi1UBL sequence as α-helix 
(only difference between methods is the length of the helix) and β-strands. Similarly, 





















































Figure 2-3. Prediction of secondary structures and order parameters for Ddi1UBL. 
Secondary structure prediction is presented in top (based on CSI method) and 
middle panel (based on TALOS+ approach). In both cases values presented on y 
axes corresponds to β-sheet secondary structure element for +1 values and α-helix 
for values equal to -1. Additionally, probability of the prediction of TALOS+ 
method corresponds to the height of the bars. Bottom, predicted order parameters 




2.3.4 Hydrogen bonds 
Another set of essential information for structure calculation is hydrogen bonds 
(H-bonds). The preparation of H-bond constraints is a two-step process. Initially, it is 
important to identify which amide protons are involved in hydrogen bonding and 
secondly it is necessary to identify the donor and acceptor for a particular H-bond. 
Using the above shown prediction, which identified residues that might be part of the α-
helix and β-strands, is useful when identifying potential residues involved in H-bonds; 
however, this information is not sufficient for the final list of H-bond constraints in the 
calculation. With use of NMR, there are two approaches that help define hydrogen bond 
constraints: amide proton-solvent exchange experiments and information obtained from 
detailed analysis of NOESY type experiments. For the first approach, a 15N-Ddi1UBL 
sample was lyophilized from the H2O based buffer and rapidly dissolved in the D2O. 
Next, a series of 1H-15N SOFAST-HMQC spectra were collected to observe changes in 
peak intensities upon exchange of protons with deuterium (HD exchange). This HD 
exchange experiment takes advantage of the fact that amide protons involved in 
hydrogen bonding are shielded from the solvent and not easily accessible for deuterium 
exchange. Consequently, amides that are easily accessible exchange with D2O solvent 
rapidly and therefore become invisible in the spectrum. For this particular study, 45 1H-
15N SOFAST-HMQC spectra were collected over time with the same set of 
experimental parameters. The only difference between experiments was the number of 
scans that were collected; series 1-14 had 4 scans, for 15-34 each experiment had 8 




number of scans is necessary to keep in mind when comparing peak intensities between 
different experiments. 
As expected, in the first experiment a number of peaks already disappeared from 
the spectrum. This was an indication that these invisible signals belong to residues with 
amide bonds that are solvent exposed and not protected by hydrogen bonding or not 
buried in the three dimensional structure. For the purpose of comparing and illustrating 
the number of signals that disappeared from the spectrum, the first spectrum of the HD 
exchange series was overlaid onto the spectrum of Ddi1UBL at the same concentration 
in protonated buffer (Figure 2-4).  
 
 
Figure 2-4. Changes in the spectrum of Ddi1UBL upon HD exchange.  1H-15N 
SOFAST-HMQC spectra overlay of 1mM 15N-Ddi1UBL in 20mM NaP buffer pH 
6.8 in H2O (blue) and first experiment from the HD exchange series of 1mM 15N-





Interestingly, when peak intensities are plotted as a function of residue number, 
it can be easily observed that most residues predicted to be part of secondary structures, 
based on the dihedral angles analysis, are still visible in the first HD exchange 
experiment (Figure 2-5). As Ddi1UBL was being exposed to D2O, intensities of the 
peaks decreased with time. After approximately 30 minutes amino acids: 3-7, 12, 14, 
17, 19, 42-47 and 69-74 lost on average half of their intensities. At the end of HD 
exchange experiment, after 245 minutes, these peaks almost disappeared from the 
spectrum. The region from residues 28 to 34 was more protected from the solvent, and 
half of these signals still had significant peak intensities at the end of the measurement.  





















Figure 2-5. Ddi1UBL peaks attenuations in the HD exchange experiment. Peak 
intensities at three time points: 5min (cyan), 30min (gray), 245min (magenta) are 
showed as bars. Intensities at the last time point were divided by 4 due to the 
difference in the number of scans. For each amino acid data are overlaid on top of 




Results of HD experiment significantly supported the CSI and TALOS+ 
prediction of residues involved in secondary structures and consequently suggested 
which amino acids are involved in hydrogen bonding.  
Secondly, it was necessary to define the pairs of amino acids that make the H-
bond. Hydrogen bonds are made between amino acids that are close in space but are not 
neighbors in the primary sequence. NOESY experiments, which provide information 
about protons close in space, are very useful tools to identify both which residues are 
involved in bond formation and the type of secondary structure this bond participates in. 
There are a few characteristic cross peaks, and their assignment helps identify H-bonds. 
For residues that are part of the α-helix, cross peaks between the amide protons of 
residue i and i+1 are observed, as well as between i and i+2, i+3 or i+4. From this 
series, the most intense peaks are for i and i+1 cross peaks and they should correspond 
to the distance of approximately 2.5Å. Additionally, cross peaks between HN and Hα 
between amino acids i and i+1, i+2, i+3 or i+4 are characteristic. Among these signals, 
due to the nature of the α-helix, the most intense signals arise from i+1 and i+3 and are 
less intense for i+2 and i+4. Considering the side chain cross peaks, signals between Hα 
and Hβ of i and i+3 residues are also distinct and can be observed as the distance 
between them is 2.5-4Å apart. In the case of β-sheets, contacts are made between two 
pieces of the sequence that can be parallel or anti-parallel to each other. Assuming that 
one sequence is around amino acid i and another around residue j, the most intense 
signals should be observed between Hα and HN of i and i+1 as well as Hα and Hα 
between i and j amino acids. The most distinguishing signature of amino acids from β-




proximity in space between amide protons of i and i+1(j and j+1) along with amide 
protons of i-1 and j+1. Where possible, all above mentioned cross peaks were assigned 
in the 2D and 3D NOESY experiments of Ddi1UBL.  
 Detailed analysis of HD exchange experiments and NOESY spectra allowed for 
preparation of an initial list of H-bonds used for structure calculation. Final hydrogen 
bond constraints used for the high resolution structure were made with support of 
information obtained from preliminary structure runs. In total, 25 hydrogen bonds were 
identified and used for structure calculation. For each bond the distance between HN and 
O was set to be 1.8Å, whereas the distance between N and O was 2.8Å; for both values 
a deviation of 0.5Å distance was allowed. 
2.3.5 Residual dipolar couplings 
Residual dipolar couplings (RDC) are a type of NMR measured properties that 
provide structural information not local in nature. These dipolar couplings can be 
observed because molecules placed in proper media align partially to the static magnetic 
field, and as a result, dipolar couplings do not average out to zero. RDCs are a type of 
long range constraints and contain information about the orientation of the individual 
amide bonds with respect to the molecular alignment frame. For the Ddi1UBL structure 
calculation only one set of RDC was collected, in which the protein was in 
PEG/hexanol-based alignment medium40. After analysis of IPAP-HSQC experiments, a 




2.4 Structure calculations 
Structure calculation was done using ARIA (Ambiguous Constraints for 
Iterative Assignment) software with the CNS engine and simulated annealing strategy74-
76. ARIA allows for automotive NOE assignment and structure calculation based on 
NMR constraints. The process of structure calculation was a cycle of multiple iterations. 
The ambiguous distance constraints from one run were used in the next run in order to 
improve results. In the last step of each calculation the refinement in explicit solvent 
was performed by molecular dynamic simulations.  
The constraints used for final structure calculations were: the protein sequence, 
the list of proton chemical shifts, the NOESY peak list, and *.tbl files with dihedral 
angels, hydrogen bonds, RDC, and the list of unambiguous assignments from the best 
previous run. The ARIA project was set with the standard setting. The structure 
calculation was done in 9 iterations (from 0 to 8), where each iteration had 100 
structures out of which the 7 best were used for the next cycle. These iterations had 
different violation tolerances and thresholds, which guaranteed improvement in 
calculations. The last iteration was water refined and the 10 best lowest energy 
structures were identified as the final result. 
2.5 Ddi1UBL structure 
All 10 lowest energy structures from AIRA presented a good convergence. They 
had a backbone RMSD of 0.39 ± 0.05 Å for the secondary structure elements and 0.80 ± 
0.16 Å for residues 2-76 (Figure 2-6). The difference between the RMSD reflects the 




and β5. The C-terminal residues 77-80 had no inter-residue NOE constraints and 
therefore are not included in this comparison.  
 
 
Figure 2-6. Structure of Ddi1UBL. Cartoon representation of backbone structure 
showing the secondary structure elements of Ddi1UBL (left) and overlay of 10 
lowest-energy structures showed as backbone traces of Ddi1UBA (right). 
 
The structure was evaluated by comparison of experimental RDC with back-
calculated values. The correlation coefficient for this data was 0.987, while the quality 
factor was equal to 0.104 (Figure2-7), confirming that the structure is correct. The 
refinement statistics including evaluation of distance and dihedral angles violation, and 
deviations from idealized geometry are summarized in Table 2-D. The R.M.S values 




Figure 2-7. Ddi1UBL structure evaluation based on RDC. The correlation between 
the experimental RDCs and their back-calculated values from the derived 
structures for Ddi1UBL. The values of the Pearson’s correlation coefficient (r) and 




Violations (mean and s.d.)  
    Distance constraints (Å)     0.05  ±  0.05 
    Dihedral angle constraints (º) 3.57  ±  0.38 
    Max. dihedral angle violation (º)     6.70 
    Max. distance constraint violation (Å)  0.22 
Deviations from idealized geometry  
    Bond lengths (Å)     0.16  ±  0.01 
    Bond angles (º) 1.26  ±  0.04 
    Impropers (º) 2.79  ±  0.17 
Average pairwise r.m.s. deviation** (Å)      
    Heavy      1.90  ±  0.35 
    Backbone   1.34  ±  0.32 
 
Table 2-D. NMR refinement statistics for Ddi1UBL structures. 
 





















2.6 Ddi1UBL vs. Ubiquitin structure comparison 
Interestingly, despite the low sequence identity to Ub, the N-terminal segment of 
Ddi1 has a domain with a Ub-like fold, in which the β-sheet is packed against the α-
helix, forming the hydrophobic core of the protein. Ddi1UBL has four full β-strands: 
antiparallel β1 and β2 strands connected through type I β turn, antiparallel β3 and β5 
strands and a short β4 strand antiparallel to β3. Lastly, strands β1 and β5 are oriented in 
a parallel manner, as in Ub. When the structure of Ddi1UBL is overlaid with the 
structure of Ub, it is observed that both Ddi1UBL and Ub have a 12 amino acid long α-
helix. However, the position of the Ddi1UBL helix is slightly different, as the helix is 
tilted such that its N-terminal end is farther away from the β-strands (Figure 2-8). 
Moreover, despite the same β-strand organization and packing against the α-helix, the 
β-sheet in Ddi1UBL appears flatter and is not wrapped around the helix as much as in 
Ub.  
When evaluating Ddi1 and Ub structure packing, most side chain contacts 
forming and stabilizing the hydrophobic core of Ub are preserved in Ddi1UBL (Figure 
2-9). These amino acids are L40 and L44 (V26 and I30 in Ub) that “anchor” the α-helix 
and L83 and I85 (L67 and L69 in Ub) that bring strand β5 to the core of the protein, as 
well as L45 and L52 (L43 and L50 in Ub) that are also conserved among Ub and 










Figure 2-8. Comparison of Ddi1UBL and Ub. Cartoon representation of the 




Figure 2-9. Ddi1UBL and Ub structure packing. Shown in pink and cyan are 
residues conserved among all the UBLs; L43, L50, T55 in Ub (left) and 
respectively L45, L52, T57 in Ddi1UBL (right). Several other residues that 
together with the abovementioned hydrophobic residues form the hydrophobic 
core in Ub (V26, I30, L67, L69) and Ddi1 UBL (L28, L32, L71, I73) are shown in 





It is clear from the sequence and structure alignment with Ub that Ddi1UBL 
does not have the classical L8-I44-V70 hydrophobic patch which is characteristic for 
Ub (Figure 1-15 and 2-10)37. However, it has a few hydrophobic residues on the surface 
of the β-sheet that may be responsible for UBL’s interactions with potential binding 
partners.  
Surprisingly, in contrast to Ub (and the other UBLs shown in Figure 1-15), 
where the hydrophobic patch is surrounded by basic side chains, in Ddi1UBL the 
hydrophobic-patch surface contains several acidic residues. 
Interestingly, amino acids D44 and D50 in Ddi1UBL are located in exactly the 
same position in the sequence as R42 and K48 are in Ub. Furthermore, E8 is very close 
to where K6 is in Ub. Such a distribution of acidic amino acids results in the opposite 
sign of the electrostatic potential of the β-sheet surface of Ddi1UBL compared to Ub 
and other UBLs (Figure 2-11). 
The dissimilarity in the distribution of surface charges suggests that although 
Ddi1UBL has a Ub-like fold and both have a hydrophobic patch differences in 
electrostatic potential might dictate different binding preferences for Ddi1UBL when 







Figure 2-10. Ddi1UBL and Ub structure comparison. (a) Spherical representation 
of hydrophobic patch (L8, I44, V70) on Ub surface with additional indication of 
H68. (b) Hydrophobic amino acids: L9, I13, M49, I51, L70, L72 (spheres) on the 
surface of Ddi1UBL that can create alternative hydrophobic binding surface. 
Representation of electrostatic potential calculated using PyMol on the surface of 
Ub (c) and Ddi1UBL (d). Negatively charged amino acids (red) and positively 
charged (blue) are shown. Negatively charged side chains of D2, E8, D44, D50 and 
D68 in Ddi1UBL are highlighted by arrows. Similarly, positively charged K6, R42, 
K48 and R72 of Ub are indicated. Major hydrophobic residues are presented to 








Figure 2-11. Electrostatic potential of the surface of Ub and the UBL domains 
from shuttle proteins: Ddi1, Rad23, and Dsk2. Positive values of the potential are 
colored blue while the negative values are red. All molecules are oriented similarly 
and such that the β-sheet surface faces the reader. The electrostatic potential map 
was generated using Pymol78. Pdb codes used for the illustration: 1Ubq.pdb for, 






2.7 Dynamic properties of Ddi1UBL 
Even though Ddi1UBL and Ub share the same fold, there are small 
dissimilarities between the two proteins. Comparison of the backbone dynamics will 
allow confirmation of the rigidity of secondary structure elements, the presence of the 
long β4/β5 loop that is more structured in Ub than in Ddi1UB and the unstructured C-
terminus.  
To address this, 15N spin-relaxation rates (T1 and T2) and steady-state 
heteronuclear 15N[1H] NOEs (hetNOE) were measured since they are sensitive to the 
overall tumbling and backbone motions of a protein. Measured 15N relaxation for 
Ddi1UBL was compared to values for Ub (Figure 2-12).  
The general pattern of R1 and R2 relaxation rates is similar between Ub and 
Ddi1UBL, however, the average 15N T1 value for Ddi1UBL is 15N T1ave = 601 ± 37 ms 
which is lower than the one for Ub (15N T1ave = 498 ± 22 ms). Consequently, the 
average Ddi1UBL 15N T2 is 112 ± 22 ms, which is higher, than for Ub. This clearly 
indicates that Ddi1UBL tumbles slower than Ub (76 a.a.) under the same conditions, 
which can be a reflection of the larger size of the Ddi1UBL construct (95 a.a.) that was 
used in these studies. In order to quantify these observations, the 15N relaxation rates 
were analyzed to determine the overall rotational correlation time (τc) of the Ddi1UBL 
construct, which was determined to be 6.77+/-0.24 ns. This τc is longer than for 
monoUb (τc = 4.85 ns) and approaches that reported for di-Ub, where the τc varies from 
7.85 ns to 8.92 ns depending on the Ub unit and linkage40,41,79,80.  
Finally, the presence of the highly flexible C-terminus in Ddi1UBL was 




52-60 exhibited noticeably lower hetNOEs compared to the rest of the backbone 
(excluding the C-terminus). This indicates that the long β4/β5 loop in Ddi1UBL is more 
dynamic than a similar loop in Ub. 






































Figure 2-12. Comparison of the 15N relaxation data in Ddi1UBL and Ub. Shown 
are backbone amides in Ddi1UBL (black) and Ub (red): hetNOE and 15N 
longitudinal R1 (=1/T1) and transverse R2 (=1/T2) relaxation rates. The elements of 




2.8 Oligomeric state of Ddi1UBL 
The slower tumbling of Ddi1UBL compared to Ub could also be interpreted as 
an indication of UBL’s self-association. In order to determine the oligomeric state of the 
Ddi1UBL construct in solution, a sedimentation equilibrium experiment was performed 
at the same sample conditions as for the NMR studies (Figure 2-13). The results 
indicate that Ddi1UBL behaves as a monomeric species with a molecular mass of 
10508 ± 406 Da (10573.89 Da expected). The fact that Ddi1UBL does not dimerize (via 
disulfide bonds) was independently confirmed by electrospray mass spectrometry 






































Figure 2-13. Sedimentation equilibrium analysis of Ddi1UBL. Shown in the top 
panel are absorbance-versus-radius profiles collected by analytical 
ultracentrifugation at three speeds: 26000 rpm (triangles), 29000 rpm (squares), 
and 32000 rpm (circles), for Ddi1UBL. The lines represent the best-fit curves 
obtained from global analysis of the data at all three speeds. The best fit of the 
data was obtained using a single-species model, which confirmed that Ddi1UBL 
indeed behaves as a monomer. The residuals of the fits are presented in the bottom 
panel. Based on the analysis the molecular mass of Ddi1UBL is 10508 ± 406 Da, in 
excellent agreement with the expected molecular mass of 10573.89 Da. Data 
collections Urszula Nowicka and Poorni Adikaram, Department of Chemistry and 








Figure 2-14. ESI-MS spectrum of DdiUBL. Ddi1UBL sample in 20mM NaP 3mM 
TCEP pH=6.8. Measured mass of Ddi1UBL was 10574.3Da (expected molecular 




Chapter 3. Ddi1- novel ubiquitin receptor 
3.1 Ddi1 as a multidomain protein 
Previously it was shown that UBL-UBA proteins homodimerize through UBL 
and UBA domains61,62. In the case of Ddi1, the intra- and inter-molecular interaction 
between the UBL and UBA domains can be ruled out based on the spectrum of the full 
length Ddi1FL where peaks of UBL and UBA domains overlay perfectly with signals of 
individually expressed domains. All these results are consistent with previously 
published data that only the RVP domain is important for Ddi1 homodimerization59,61.   
In the spectrum of the full length Ddi1, except for the peaks of UBL and UBA 
domains there are some additional peaks towards the middle of the spectrum. The 
number of peaks is less than expected for RVP domain. Moreover, in the hetNOE 
experiment negative peak intensities or near zero intensities are observed for these 
signals, indicating that they belong to some unstructured and/or flexible region of Ddi1 







Figure 3-1. Heteronuclear NOE spectrum of full length Ddi1. Red contours show 
positive signal intensities, green contours correspond to negative intensities, 
indicating flexibility of the amide group. 
 
Except for being responsible for homodimerization and for its involvement in 
pds1-128 rescue, no other function for the RVP domain, especially in the UPS system, 
was reported58. We wanted to test whether this retroviral protease fold domain has any 
protease activity against Ub chains. For that purpose, we tested full length Ddi1 against 
deubiquitinase (DUB) activity for all seven lysines linked Ub2. we did not observe any 
chain cleavage even after extending the experimental time to 24 hours, indicating that 





Figure 3-2. Time resolved deubiquitinating enzyme (DUB) activity assay, testing 
for Ddi1 protease activity against K6-, K11-, K27-, K29-, K33-, K48- and K63-
Ub2s. Sample of each individual chain was incubated with Ddi1FL. Time points 
were collected as indicated on top of each gel. No Ddi1FL DUB activity was 




Combining all the information mentioned above, including how UBL, RVP and 
UBA domains tumble independently from each other, as well as the fact that no 
interaction exists between UBA and UBL domains, and that the RVP domain is 
responsible for Ddi1 homodimerization allowed to propose a model of the FL Ddi1 
structure, in which all three domains are connected through flexible linkers (Figure 3-3).  
 
 
Figure 3-3. Model structure of Ddi1FL. Model obtained based on NMR data with a 
use of Ddi1UBA (courtesy Daoning Zhang) and Ddi1UBL structures from these 





3.2 Ddi1 interacts with ubiquitin not only through the UBA domain 
It was already shown that the UBA domain of Ddi1 binds Ub32. This 
phenomenon was also confirmed in detail using NMR studies performed by Daoning 
Zhang, who estimated that Ddi1UBA and Ub interacts with an equilibrium constant of 
150 ± 16 μM (data not shown). While all NMR studies performed thus far were for the 
isolated UBA domain of Ddi1, we wanted to test whether these observations hold in the 
context of full-length Ddi1. For this, we performed NMR binding experiment with Ub 
and full length Ddi1. Two molar excess unlabeled Ub was added to 15N labeled FL Ddi1 
sample and 1H-15N TROSY spectrum was collected and compared to the spectrum of 
Ddi1FL alone (Figure 3-4).  
As expected, signals corresponding to the Ddi1UBA domain shifted with the 
same magnitude and direction as for the isolated UBA. Surprisingly, in addition to the 
shifts of Ddi1UBA domain signals, a greater change in signal positions and intensities 
for residues corresponding to the Ddi1UBL domain was observed. This entirely 
unexpected result indicates that Ddi1 interacts with Ub not only through the UBA 






Figure 3-4. Ddi1FL binding to Ub. Overlay of the 1H-15N TROSY spectrum of FL 
Ddi1 alone (blue) and in the presence of Ub at 1:2 molar ratio (red). Single arrow 
represent shifts of UBL domain peaks, double arrow show shifts in UBA domain.  
 
3.3 Ddi1UBL interacts with ubiquitin 
UBL-domain signals in the FL Ddi1 spectrum were more affected by the 
presence of Ub than the signals of the UBA domain. The interaction of a UBL domain 
with Ub itself has never been reported; therefore we examined Ub binding to an isolated 
Ddi1UBL domain. When Ub was added to 15N-labeled Ddi1UBL, a number of residues 






Figure 3-5. Ub binding to Ddi1UBL. Overlay of the 1H-15N SOFAST-HMQC 
spectra of the free Ub (blue) and Ub bound to Ddi1UBL domain (red) at saturation 
(Ddi1UBL:Ub molar ratio1:5.7). Insets show zoom on selected regions to illustrate 





Figure 3-6. Amide chemical shift differences in Ddi1UBL upon Ub binding. CSP 
was obtained at the bound state at the endpoint of titration (molar ratio 1:5.7). 
Asterisks indicate P16 and those residues where N-H resonances cannot be 
followed in the spectra due to overlaps. 
 
Mapping residues with CSPs > 0.075 ppm at the endpoint of titration, on the 
Ddi1UBL structure allowed for the identification of a putative binding site for Ub 
(Figure 3-7). Ub binding mostly affected residues located on all five β-strands of 
Ddi1UBL, thus forming a binding surface on the β-sheet side of the protein. It appears 
that the interaction with Ub is mediated through nonpolar and hydrophobic amino acids 
G11, L52, L70 but also by some polar and charged residues: T4, S6, E12, N48, K66 and 
T67. By contrast, the opposite (α-helix) side of Ddi1UBL does not appear to be 
involved in Ub binding, as inferred from the almost negligible CSPs observed here. It 




Ddi1UBL is consistent with the location of the ligand-binding site on Ub and other 
UBL proteins36-38,81,82.  
 
 
Figure 3-7. Putative Ub-binding site on Ddi1UBL. Mapping the putative Ub-
binding site (orange) on the Ddi1UBL surface (green). CSPs threshold >0.075 ppm 
was used for mapping in both cases. 
 
The best fit of titration curves was obtained for the 1:1 binding model and gave an 
average Kd value of 45±15 µM (Figure 3-8). The 1:1 stoichiometry of binding is 
supported by the 15N T1 data where Ddi1UBL alone has an average T1 equal to 601±37 
ms, while at the titration endpoint, the average T1 is 951±52 ms, which corresponds 
approximately to the rate that would be expected for moiety of the size of the 





Figure 3-8. Titration curves for Ub binding to Ddi1UBL. Titration curves for 
representative residues from the β-sheet of 15N-Ddi1UBL involved in interaction 
with Ub. The lines show fits of the data to a 1:1 binding model. 15N-Ddi1UBL 
starting concentration was 250µM. 
 
3.4 Ubiquitin interacts with Ddi1UBL through the hydrophobic-patch 
residues 
The unexpected interaction involving Ub raised the question as to whether Ub 
interacts with Ddi1UBL through the same (hydrophobic-patch) surface as other known 
Ub ligands, or through a different binding site. To address this question, we titrated 15N-
labeled Ub with unlabeled Ddi1UBL. Upon addition of Ddi1UBL, a number of amide 
signals of Ub changed their resonance positions significantly (Figure 3-9). Moreover, 




which is consistent with slow exchange on the NMR chemical shift time scale, 
indicative of tight binding.  
 
 
Figure 3-9. Titration spectra of 15N-Ub with Ddi1UBL. Superposition of 1H-15N 
SOFAST-HMQC spectra of 15N-labeled Ub alone (blue) and saturated with 
Ddi1UBL (molar ratio 1:5). Signal shifts of the residues used for Kd estimation are 
shown in insets. A46 and G47 showing slow exchange upon ligand binding are 






Interestingly, the overall magnitude of the observed CSPs is similar to that of 




Figure 3-10. CSP between free Ub and Ub upon saturation with Ddi1UBL. 
Saturation was achieved at 1:5 molar ratio. P19, P37 and P38 are marked with 
asterisks; additionally E24 that is in fast exchange and I36 that does not appear in 
the SOFAST spectrum are marked with asterisks. 
 
Mapping the observed CSPs on the structure of Ub confirmed that Ub interacts 
with Ddi1UBL through the same “canonical” hydrophobic patch (centered at residues 
L8-I44-V70) used to bind other known Ub-ligands (Figure 3-11)36-38. Finally, the 
analysis of titration curves gave the dissociation constant Kd=71±9 µM (averaged over 




looking at 15N Ddi1UBL and adding Ub (Figure 3-12). The 15N relaxation rates gave an 
average T1 equal to 956±53 ms, confirming the 1:1 stoichiometry of binding with 
support from the 1:1 model that gave the best fit of titration curves.  
 
 
Figure 3-11. Putative binding side for Ub on Ddi1UBL structure. Ddi1UBL 
binding site is shown in green on the surface of Ub (orange). Ub structure obtained 
from 1Ubq.pdb. 
 
Figure 3-12. Representative titration curves for 15N-Ub binding to Ddi1UBL. Data 




3.5 Ddi1 UBL pulls out ubiquitin conjugates from cell extract 
The binding between Ddi1UBL and Ub was also independently verified by a 
pull-down/IP experiment (Figure 3-13), where immobilized 6xHis-Ub pulled down 
purified Ddi1UBL, thus providing additional evidence of a physical interaction between 
the two proteins and confirming the results of NMR studies. 
 
 
Figure 3-13. 6xHisUb Co-immunoprecipitates Ddi1UBL. Purified 6xHisDDI1UBL or 
6xHisUb was incubated with activated CH-sepharose beads and then incubated with 
6xHisUb or 6xHisDDI1UBL respectively. Beads were boiled for elution. Data courtesy 
Daria Krutauz and Michael H. Glickman, Department of Biology, Technion–Israel 
Institute of Technology, 32000 Haifa, Israel. 
 
 Furthermore, 6xHis-Ddi1UBL was capable of pulling out Ub-conjugates from 
the yeast cell extract lacking Ddi1, DDI1∆ (Figure 3-14). The latter result suggests that 






Figure 3-14. Ddi1UBL pull out ubiquitin conjugates from cell extract. As 
previously, purified 6xHisDDI1UBL or 6xHis Ub were incubated with activated CH-
sepharose beads. Total protein extract was obtained from growing DDI1Δ yeast 
cells (strain lacking Ddi1 gene). Beads loaded with proteins were incubated with 
cell extract. Elution was performed by beads boiling.  Data courtesy Daria 
Krutauz and Michael H. Glickman, Department of Biology, Technion–Israel 
Institute of Technology, 32000 Haifa, Israel. 
 
3.6 Ub interacts with UBL domain of Ddi1 but not of Dsk2 or Rad23 
Furthermore, we were interested in examining whether the UBL domains from 
other UBL-UBA shuttle proteins interact with Ub. To test it, the UBL domains of 
Rad23 and Dsk2 were titrated into 15N-labeled Ub. No changes in the Ub signal 
positions were observed, indicating that neither Rad23UBL nor Dsk2UBL interacts 
with Ub (Figure 3-15). These results confirm that the Ddi1UBL:Ub interaction is 






Figure 3-15. NMR titration of Ub with the UBL domains from Dsk2 and Rad23. 
On the left, 1H-15N SOFAST-HMQC spectra overlay of 15N-Ub alone (red) with the 
spectrum of 15N-Ub sample to which Dsk2UBL was added at 1:5 molar ratio 
(blue). A similar experiment is shown on the right, however, the spectrum of 15N-
Ub (red) is overlaid with the spectrum of 15N-Ub mixed with Rad23UBL (blue) at 
1:2 molar ratio. In both cases the spectra overlay perfectly indicating there is no 
interaction between Ub and Dsk2UBL as well as Ub and Rad23UBL. 
 
3.7 Structure of the Ub:Ddi1UBL complex 
As the interaction of Ub and Ddi1UBL is novel and has not been previously 
studied, we wanted to characterize the structure of this complex. The Ddi1UBL 
structure and Ub structure obtained from 1Ubq.pdb were used for docking. A structural 
model of the complex was obtained using the biomolecular docking software 
HADDOCK83-85, along with two sets of experimental intermolecular NMR constraints: 
(1) ambiguous constraints based on the observed CSPs (Table 3-A) and (2) long-




(PRE) detected in 15N-Ddi1UBL after attaching a nitroxide spin-label (MTSL) to 
residue 12 of Ub (UbT12C variant), in a 1:1 Ub: Ddi1UBL complex. The derived 
structure of the Ub:Ddi1UBL complex is shown in Figure 3-16. The backbone RMSD 




Active Residues 6,8,9,12,46,47,49,68,71,72,73 
Passive Residues 2,10,14,39,44,48,51,52,64,74,75,76 
Ddi1UBL 
Active Residues 4,8,11,12,15,17,48,49,50,53,66,67,68 
Passive Residues 1,2,6,9,10,13,16,21,44,46,51,54,55,56,58,64,70,72,74,75 
 
Table 3-A. Active and passive residues used for docking of Ub-Ddi1UBL 
complexes. Docking was performed with HADDOCK software. Identification of 
active and passive residues was done based on the information from titration data 
with support of NACCESS analysis that allows for quantification of individual 








Ub:Ddi1UBL Complex Constraints 
Distance 
















2 HN 15.84 
2 CYM OAH 3 HN 16.07 
3 CYM OAH 4 HN 15.39 
4 CYM OAH 17 HN 17.75 
5 CYM CYM 48 HN 14.51 
6 CYM OAH 49 HN 15.02 
7 CYM OAH 50 HN 16.71 
8 CYM OAH 64 HN 15.97 
9 CYM OAH 65 HN 12.84 
10 CYM OAH 66 HN 11.14 
11 CYM OAH 67 HN 9.95 
12 CYM OAH 68 HN 9.12 
13 CYM OAH 69 HN 11.3 
14 CYM OAH 70 HN 14.2 
 
Table 3-B. Distance constraints for Ub:Ddi1UBL complex based on MTSL studies.  
The spin label was attached to residue 12 in Ub (UbT12CD77) and signal 
attenuation was observed on 15N-Ddi1UBL. The MTSL attached to Cys12 is 







Figure 3-16. Haddock derived structure of the Ub:Ddi1UBL complex. Ddi1UBL is 
shown in green while and Ub is shown in orange. Overlay of five structures of 
Ub:Ddi1UBL complex from the top cluster generated by HADDOCK. Shown are 
backbone traces for Ub (orange) and UBL (green), superimposed by secondary 
structure elements; the backbone RMSD was 0.94 ± 0.33 Å. Complex was obtained 
with help of Olivier Walker, Institut des Sciences Analytiques, UMR5280-




To further examine the structure, the coordinates of Ddi1UBL in the complex 
were used to reconstruct the position of the spin label on Ub from the complex 
structure. The calculated position matched almost ideally the position of the ubiquitin 
cysteine residue to which MTSL was attached (Figure 3-17a).  To independently 
validate the structure of the Ub:Ddi1UBL complex, we used two separate sets of site-
specific spin labeling/PRE data that was not used for the docking. Specifically, as a 
positive control, we attached MTSL to residue 75 in Ub (Ub G75C), and, in a separate 
experiment, to residue 63 (UbK63C), as a negative control. The experimental data 
showed a strong site-specific PRE effect on Ddi1UBL when MTSL was placed on 
Cys75 of Ub. When the complex structure was used to reconstruct the spin label’s 
position, the back-calculated attenuations in signal intensities matched those observed 
experimentally. Furthermore, the reconstruction placed the MTSL in close proximity as 
well, thus confirming that the Ub/Ddi1UBL structure is correct (Figure 3-17b). Finally, 
we did not detect any major/systematic PRE effects in Ddi1UBL when MTSL was 
attached to UbK63C. In the complex structure the distance between residue 63 of Ub to 
amides of Ddi1UBL is about 25Å, which is the MTSL’s PRE range, hence is too far to 








Figure 3-17. Validation of the NMR-derived (HADDOCK) structure of 
Ub:Ddi1UBL complex using site-specific paramagnetic spin-labeling. Signal 
attenuations in Ddi1UBL caused by MTSL attached to the proper cysteine mutant, 
T12C (a), G75C (b) and K63C (c). On the left, signal attenuations in Ddi1UBL 
from experimental data (blue bars) and calculated based on the complex structure 
(red squares), overlapping signals are marked with asterisks. The positions of the 
spin label’s unpaired electron reconstructed from experimental data in the 
complex structure for each of the mutant are shown as spheres. Locations of the 
amino acids that were muted to Cys are indicated as sticks. Ub structure is 






When studying the Ud:Ddi1UBL complex interface in detail it can be noticed 
that the interaction between the two proteins is mainly mediated through side chains of 
hydrophobic amino acids (Figure 3-18 and 3-19). Ub exploits its classical hydrophobic 
patch: L8-I44-V70, whereas Ddi1UBL utilizes I13, L70, and L72 that corresponds to 
the analogous hydrophobic patch on the UBL surface. The total buried surface area due 




Figure 3-18. Interface between Ddi1UBL and Ub. Hydrophobic amino acids are 
shown as blue spheres, polar and charged amino acids are in salmon. Ribbon 
colors Ub (orange), Ddi1UBL (green). 
 
As shown the hydrophobic interaction is stabilized by several electrostatic and 
polar contacts surrounding hydrophobic amino acids of both complex components. An 
example of such a pair of contacts is the interaction of K6 (Ub) with D68 (Ddi1), R42 






Figure 3-19. Side chains contacts at the interface of the Ub:Ddi1UBL complex. 
Hydrophobic amino acids of Ub: L8, I44, V70 (orange) and Ddi1: I13, L70, L72 
(green) are shown as spheres. In sticks are shown amino acids of Ub: K6, R42, 
H68, R72 (pink) and Ddi1UBL: D2, E8, D68 (green) that create polar contacts 
(yellow dash lines). 
 
3.8 Ufo1UIMs interact with ubiquitin but not with Ddi1 
As mentioned above, Ufo1 was the only identified binding partner that 
interacted with Ddi1UBL56. Therefore, we wanted to study Ddi1 binding to the UIM 




unlabeled Ufo1UIMs construct containing three UIM domains (Figure 3-20a). 
Surprisingly, despite reaching a very high saturation, even at the Ufo1UIMs:Ddi1UBL 
molar ratio of 10:1 no significant changes in the Ddi1 spectrum were detected (Figure 
3-20b).  
 
Figure 3-20. Ufo1UIMs binding to Ddi1UBL. (a) Demonstration  of lack of changes 
in the Ddi1UBL spectrum (red) under presence of Ufo1UIM  in the sample (blue) 
at 1:10 molar ratio.  (b) CSP quantification of Ddi1UBL interaction with 
Ufo1UIMs at saturation. 
 
To verify the lack of binding between the two proteins, a reverse titration was 
performed, by adding unlabeled Ddi1UBL to 15N-labeled Ufo1UIMs; the Ufo1UIMs 
signals also did not show any perturbations even at 10-fold excess of Ddi1UBL (Figure 
3-21a). A similar lack of binding was observed in FL Ddi1 when titrating it with 
Ufo1UIMs up to 10:1 molar ratio (Figure 3-21b). Combined, all these results indicate 





Figure 3-21. Lack of interaction of Ufo1UIM with Ddi1UBL and Ddi1FL. (a) 
Overlay of the 1H-15N SOFAST-HMQC spectrum of Ufo1UIM (red) upon 
saturation (blue) with Ddi1UBL. (b) Overlay of the 1H-15N TROSY spectrum of 
15N-Ddi1FL alone (red) and saturated with Ufo1UIM (blue), also at 1:10 molar 
ratio. 
 
Since it was known that the Ddi1FL and Ddi1UBL protein samples were active, 
we wanted to confirm that the Ufo1UIMs protein is in its folded state after expression 
and purification and therefore capable of performing its function. The CD spectrum of 
Ufo1UIMs confirms the presence of α-helical and some random coil elements, which 
matches prediction that Ufo1 has UIM helices connected through unstructured linkers 






















Figure 3-22. CD spectrum of Ufo1UIM. The CD spectrum was measured in 20mM 
NaP buffer pH 6.8. 
 
If a protein that has three UIM domains is active, the addition of Ub should 
promote changes in the Ufo1UIMs’ spectrum. As expected, when the 15N Ufo1UIMs 
sample was mixed with Ub at a 1:1 ratio, shifts and signal attenuations several residues 
were observed (Figure 3-23a). Confirmation of binding was also observed when 15N Ub 





Figure 3-23. Ufo1UIMs recognize Ub. (a) Comparison of the peaks position in the 
spectrum of Ufo1UIM alone (red) and upon addition of Ub (blue), ratio 1:1. (b) 
Reference 1H-15N spectrum of Ub (red) overlaid with the spectrum of Ub mixed 
with Ufo1UIM at 1:1 ratio (blue). Some of the major shifts in the peak positions 
are indicated with arrows. 
 
A full titration of 15N Ub with Ufo1UIMs was performed until saturation was 
reached (at 5:1 molar ratio) which allowed quantification of changes in the Ub spectrum 
using CSP (Figure 3-24a). As above, residues with significant CSPs allowed the 
identification of the hydrophobic patch as being the site for Ufo1UIMs binding (Figure 
3-24b).  
Taking into account the presence of three UIMs in Ufo1UIMs, the average 







Figure 3-24. Ub recognizes Ufo1UIMs through the hydrophobic patch. (a) CSP 
plot for Ub at titration endpoint (Ub:Ufo1UIM ratio =1:5). (b) Illustration of 
position where UIM domains of Ufo1 bind to Ub (cyan), Ub showed in orange. Ub 
structure was taken from 1Ubq.pdb.  
 
 
Figure 3-25. Representative titration curves for Ufo1UIMs binding to Ub. Shown 





3.9 Ddi1UBL and Ub:Ddi1UBL complex crystallization  
To further understand the protein structures and interactions, Ddi1UBL as well 
as the Ub:Ddi1UBL complex can be crystallized. For the purpose of crystallization both 
samples were kept in 20mM HEPES buffer at pH 7.5.  For screening crystallization 
conditions, the following types of screening suites were used: Index (Hampton), Wizard 
I and II (Emerald), PEG Suite (Qiagen), Cryo Suite (Qiagen), Natrix (Hampton). For 
Ddi1UBL, a concentration of 22mg/µL was used, while the complex sample 
concentration was 52 mg/µL. Precipitant was present in a number of conditions in PEG, 
Index, Wizard I and II and Natrix suites both for Ddi1UBL alone as well as for the 
complex. The Cryo suite had only a few hits with precipitation for Ddi1UBL but not for 
the complex. The crystals were only observed for the Ub:Ddi1UBL complex in the 
INDEX suite and the most promising results were in the following conditions (Figure 3-
26): 
– INDEX 3:  0.1 M BIS-TRIS pH 5.5, 2.0 M ammonium sulfate 
– INDEX 6:  0.1 M Tris pH 8.5, 2.0 M ammonium sulfate 
– INDEX 20: 0.1 M HEPES pH 7.5, 1.4 M sodium citrate tribasic 
dehydrate 
– INDEX 21: 1.8 M ammonium citrate tribasic pH 7.0 
– INDEX 27: 2.4 M sodium malonate pH 7.0 










Figure 3-26. Potential crystal hits of Ub:Ddi1UBL complex from the INDEX 
screening suite. a) INDEX 6:  0.1 M Tris pH 8.5, 2.0 M ammonium sulfate; b) 
INDEX 20: 0.1 M HEPES pH 7.5, 1.4 M sodium citrate tribasic dehydrate; c) 








Chapter 4. Ddi1UBL, first known ubiquitin like 
domain with a UIM motif 
4.1 Ddi1 heterodimerization with other shuttle proteins 
As previously mentioned, it is common for the shuttle proteins to homo- and 
hetero-dimerize. Till now, it was thought that these interactions were mediated through 
the classical binding of UBA to UBL domains. It is unclear whether and how Ddi1 is 
involved in heterodimerization with Dsk2 and Rad23. Due to this reason, and because 
of the unusual properties of Ddi1UBL, we wanted to study the interactions between the 
shuttles in detail, with the main focus on Ddi129,30,61. Ideally both UBA and UBL 
domains can be used for interactions with Dsk2 and Rad23; therefore first we tested 
interactions between FL Ddi1 and the UBL domains of Rad23 and Dsk2 (Figure 4-1). 
As shown, Ddi1 binds differently to Dsk2UBL and Rad23UBL. Upon addition of 
Rad23UBL to Ddi1FL only a limited number of changes are observed, in the case of 
Dsk2UBL the changes in the spectrum are significant. Moreover, signals arising from 
the Ddi1UBL are very often invisible, while signals of the UBA domain of Ddi1 show 
just small shifts. This indicates that there is significant interaction between Ddi1UBL 





Figure 4-1. Binding of UBL domains of Dsk2 and Rad23 to full length Ddi1. The 
spectrum of FL Ddi1 is shown in red, and the spectrum obtained upon binding is 
shown in blue. Top, 250µM 15N-Ddi1FL at 1:3 ratio with the UBL domain of Dsk2. 




We also wanted to check how the spectrum of full length Dsk2 and Rad23 
would be affected in the presence of the Dd1iUBL domain (Figure 4-2). When Dsk2FL 
is titrated with Ddi1UBL, signals that correspond to the Dsk2UBL domain either 
attenuate or show shifts that complement results from previously observed binding 
experiments. As expected, in the case of Rad23 there are no easily noticed differences 






Figure 4-2. Binding of UBL domain of Ddi1UBL to full length Dsk2 and Rad23. 
The spectra of FL constructs are shown in red, while the spectra obtained upon 
binding are shown in blue. Top, 165µM 15N-Dsk2FL at 1:1 ratio with Ddi1UBL. 
Insert shows the spectrum of 250µM 15N-Dsk2UBL in magenta. Bottom, 610µM 




As a final confirmation that a significant interaction between Rad23UBL and 
Ddi1UBL does not exist, similar studies were performed using construct with only the 
UBL domain of Rad23 (Figure 4-3). Only a limited number of peaks changed position 
in the presence of Ddi1UBL, and these changes were not as drastic as in the case of 




Figure 4-3. Ddi1UBL binding to Rad23UBL. 250µM 15N-Rad23UBL (red) in the 






Lastly, the absence of interactions between the UBA domain from Rad23 and 
Ddi1UBL was confirmed by individual titration of Ddi1UBL with the UBA2 domain of 
hHR23A, the human homolog of Rad23 (hRad23) and the UBA domain of UBQLN1, 
the human homolog of Dsk2 (Figure 4-4). There were no changes in the spectrum of 
Ddi1UBL upon addition of each of the ligands. These human homologs share on 
average sequence similarity of 70% and 60%, respectively, with yeast sequences. Based 
on the above results, it can be assumed that despite the fact that both constructs were 
obtained from the Homo sapiens, Ddi1UBL doesn’t interact with the UBA2 domain of 
Rad23 as well as the UBA domain of Dsk2. The interaction between Ddi1UBL and the 
UBA1 of Rad23 was not tested. It is worth mentioning that this interaction was 







Figure 4-4. Ddi1UBL interaction with hDsk2UBA and hRad23UBA2. The spectra 
of the UBL domains of Ddi1 alone are shown in red, and the spectra upon binding 
are in blue. Top, 250µM 15N-Ddi1UBL was mixed with a sample of H.sapiens UBA 
domain from Dsk2 at 1:2 ratio (this construct had additionally introduced Tyr for 
easier estimation of concentration). Bottom, 250µM 15N-Ddi1UBL titrated with 




4.2 Dsk2UBL binding to Ddi1UBL 
The fact that a number of peaks belonging to Dsk2UBL either disappeared or 
shifted in the spectrum of Dsk2FL in the presence of Ddi1UBL motivated us to study 
the interaction between Dsk2UBL and Ddi1UBL in more detail. For that purpose, a full 
titration was performed by adding increasing amounts of unlabeled Ddi1UBL to a 
250µM sample of Dsk2UBL. Saturation, the point at which no more changes in the 
spectrum was observed, was achieved when Dsk2UBL and the UBL domain of Ddi1 
were mixed in 1:4.5 ratio (Figure 4-5). Consistent with results obtained from full length 
Dsk2, a number of peaks significantly changed their position.  
 
Figure 4-5. Interaction of UBL domains from Dsk2 and Ddi1. In red, the spectrum 
of 250µM Dsk2UBL, while in blue is the spectrum of Dsk2UBL saturated with 




Changes in the spectrum were quantified as CSP (Figure 4-6) and were used to 
identify putative binding sites on the structure of Dsk2UBL (Figure 4-7). A number of 
residues involved in the interaction showed attenuation, and therefore could not be used 
for Kd estimation. 
Residues that showed significant chemical shift perturbations (CSP>0.1) were 
used to obtain the affinity of this interaction. The best fit was obtained for the 1:1 
binding with an affinity of 16±10 µM.  The 15N relaxation rates gave an average T1 
equal to ~1170ms, slightly greater than for Ddi1UBL:Ub. Further estimation of the 
binding affinity and stoichiometry of this interaction will require additional 
experimentation, preferably from another technique that is not residue specific.  

















Figure 4-6. Chemical shift perturbations of Ddi1UBL binding to Dsk2UBL. CSP 
obtained at saturation (ratio 4:5). Light gray bars represent peaks that attenuated. 





Figure 4-7. Putative Ddi1UBL binding site on the surface of Dsk2UBL. Amino 
acids showing CSP>0.05 at saturation are mapped in yellow on the Dsk2UBL 
model (2BWF.pdb) shown in light blue color.  
 
4.3 Ddi1UBL has an additional binding site for Dsk2UBL 
Having observed significant differences for the UBL domain in the spectrum of 
the full length Ddi1, it was important to determine whether Ddi1UBL uses the same 
binding site for the UBL domain of Dsk2 as it does for Ub. The above titration 
demonstrated that the number of Ddi1UBL peaks change position; however, because 
the Ddi1FL spectrum is very crowded, further characterization was performed using 
individual domains. A number of shifts can be observed when comparing the spectrum 






Figure 4-8. Dsk2UBL binding to Ddi1UBL. Spectra of 250µM 15N-Ddi1UBL alone 
(red) and in the presence of Dsk2UBL at 1:5 ratio (blue). 
 
Detailed analysis of the full titration is very complicated as a number of peaks 
overlap, rendering it difficult to estimate their final position. For the purpose of 
illustration, at a 1:1 ratio of proteins, the amino acids affected by binding can be 
identified (Figure 4-9). Chemical shift perturbations of peaks observed at 1:1 ratio 
reveal that most of the amide groups in Ddi1UBL were affected by binding of 























Figure 4-9. Chemical shift perturbations upon Dsk2UBL binding to 15N-Ddi1UBL. 
CSP obtained between peak positions in spectrum of Ddi1UBL and spectrum of 
Ddi1UBL in the presence of Dsk2UBL at 1:1 ratio. Light gray bars highlight 
residues with peaks attenuated.  
 
When CSPs at this ratio were mapped on the structure of Ddi1UBL, it was 
observed that in addition to the binding site that was utilized for Ub binding, Dsk2UBL 
also interacts with the long loop of Ddi1UBL and, more importantly, with the α-helix of 
the UBL domain of Ddi1 (Figure 4-10). The 15N relaxation rates yielded an average T1 







Figure 4-10. Putative Dsk2UBL binding site on the surface of Ddi1UBL. Ddi1UBL 
is shown in green. Amino acids with CSP>0.05 at 1:1 ratio are used to indicate 
Dsk2UBL binding site and are colored in magenta. 
 
Finally, we wanted to determine whether Dsk2UBL competes with Ub for 
binding to Ddi1UBL. The experiment was designed to first observe binding of 
Ddi1UBL to 15N-Ub, then take advantage of the fact that Dsk2UBL does not bind Ub 
(as shown in Chapter 3.6) and add Dsk2UBL to the same sample. If binding between 
Dsk2UBL and Ddi1UBL is stronger than Ddi1UBL to 15N-Ub, upon addition of 
Dsk2UBL the spectrum should resemble the spectrum of 15N-Ub in its unbound state, 
since only signals from Ub are visible. 15N-Ub and Ddi1UBL were mixed in a 1:1 ratio. 
Since, Dsk2UBL can have two binding sites for the UBL domain of Ddi1, a double 
molar amount of Dsk2UBL was added to the tube to compensate for this. When the 
three spectra were overlaid with each other: 15N-Ub alone (red), 15N-Ub / Ddi1UBL 
mixed at 1:1 ratio (blue) and 15N-Ub / Ddi1UBL /Dsk2UBL mixed at ratio 1:1:2 (cyan) 




considering the trajectories of the peak shifts, it can be assumed that some Ub was 
release from the Ddi1UBL since the peaks shifted back to their original positions in the 
unbound state. This result suggests that both Ub and Dsk2UBL display similar ranges of 
affinity towards Ddi1UBL. 
 
 
Figure 4-11. Competition assay between Ub, Ddi1UBL and Dsk2UBL. In red, 
spectrum of 250µM sample of Ub. In blue, spectrum of 250µM Ub with unlabeled 
Ddi1UBL sample added in equal molar amount. In cyan, spectrum of the above 
mentioned sample to which double molar excess of Dsk2UBL sample was added 





4.4 Ddi1UBL differentiates between different linkages of Ub2 
Research performed up to now indicated that Ddi1UBL binds not only Ub but 
also UBL domains such as Dsk2UBL. We wanted to determine whether Ddi1UBL also 
binds diUbs, two Ub that are connected through an isopeptide bond, in the same manner 
as mono Ub. We tested the interaction between Ddi1UBL and Ub2, where Ub are linked 
through K48 (K48-Ub2) and through K63 (K63-Ub2).  These two linkages are 
particularly interesting because they display two distinguishing open and close 
conformations of Ub2 that dictate the orientation and accessibility of hydrophobic 
patches on the Ub surface. When the spectrum of Ddi1UBL alone is compared with the 
spectrum of Ddi1UBL in the presence of each of these dimers, it can be observed that a 
number of peaks were affected in both cases (Figure 4-12). Furthermore, in the case of 
K48-Ub2 binding, a number of peaks shift, but there are also peaks that disappear 







Figure 4-12. Comparison of K48-Ub2 and K63-Ub2 binding to Ddi1UBL. Spectra 
of 250µM 15N-Ddi1UBL are shown in red. Top, spectrum of 15N-Ddi1UBL in the 
presence of K48-Ub2 at 1:0.5 ratio is shown in blue. Bottom, in blue spectrum of 




More interestingly, we wanted to determine whether there were any similarities 
between peak positions in the spectrum of Ddi1UBL bound to Ub, with the spectra of 
Ddi1UBL bound to each of these dimers (Figure 4-13). For consistency all Ub2 bound 
states were compared with appropriate ratios between Ddi1UBL and Ub. Fascinatingly, 
the spectrum of the UBL domain of Ddi1 bound to K63-Ub2 is almost the same as the 
spectrum of Ddi1UBL bound to Ub at the same ratio. On the contrary, the spectrum of 
Ddi1UBL bound to K48-Ub2 does not fully match the spectrum of Ddi1UBL to Ub. 
These results indicate that the UBL domain of Ddi1 distinguishes between K48-Ub2 and 
K63-Ub2 and that they have different conformations. K63-Ub2, which is more open 
enables each Ub moiety to bind DdiUBL in the same way as mono Ub does, therefore 
no difference in the spectra of the bound states is observed. K48-Ub2, on the other hand, 
has Ub moieties that interact with each other and are in closer proximity, and as a result 
might increase local concentration of Ub that is available for Ddi1UBL, allowing 






Figure 4-13. Ddi1UBL differentiates between K48-Ub2 and K63-Ub2. On top, 
comparison of bound states of Ddi1UBL in the presence of monoUb (red) and in 
the presence of K48-Ub2(blue). Both bound states are at the same ratio, 1:0.5. On 
bottom, a similar type of comparison but Ddi1UBL:monoUb spectrum at 1:1 ratio 





It was also interesting to observe how the chemical shift perturbations were 
distributed when reported as a function of the residue number (Figure 4-14). The CSP 
plot of Ddi1UBL binding to K63-Ub2, despite being at a different ratio than the plot in 
Figure 3.6 resembles it very closely. This indicates that the binding of K63-Ub2 
comprises the same binding site as binding of mono Ub. In the case of K48-Ub2, it 
seems that perturbations are distributed throughout the sequence, including the α-helix. 






























Figure 4-14. CSP between free Ddi1UBL and Ddi1UBL bound to K48-Ub2 and 





4.5 Ddi1UBL has UIM-like motif sequence in its α-helix 
The surprising result, that both Dsk2UBL and K48-Ub2 interact with the α-helix 
of Ddi1UBL, was the main reason to further investigate this part of the Ddi1UBL amino 
acid sequence. After close analysis, we found that within the α-helix sequence there is a 
stretch of hydrophobic amino acids that is not present in the α-helix of Ub and UBL 
domains of other shuttle proteins (Figure 4-15). 
 
 
Figure 4-15. Sequence alignment of the α-helix amino acids of Ddi1UBL and α-
helix sequence in Ub, Dks2UBL and Rad23UBL. 
 
The presence of these hydrophobic amino acids resembles the sequence of the 
UIM motifs that is known to interact with Ub. The traditional UIM sequence is a series 
of hydrophobic residues such as LALAL or LAMAL that is terminated by the 
conserved Ser residue. For the purpose of analysis the sequence of the Ddi1UBL α-
helix was compared with the sequence of known UIM motifs (Figure 4-16). Despite the 
fact that Ddi1UBL doesn’t have a Ser residue at the end of the sequence it does have a 
LIALL sequence that is very similar to the sequence characteristic for UIM motif. It 
will be interesting to see if introducing mutations at this part of the α-helix will affect 






Figure 4-16. Sequence alignment of the α-helix amino acids of Ddi1UBL and other 
known UIM motif sequences. 
 
4.6 Ddi1UBL mutants with altered UIM-like motif sequence 
Since both Dsk2UBL and K48-Ub2 interact with the Ddi1UBL α-helix and the 
hydrophobic amino acids within it, the goal was to determine whether the UIM-like 
motif is responsible for recognitions of binding partners on the second binding site. To 
test this hypothesis three mutants were made: Ddi1UBL_S, Ddi1UBL_SK and 










Figure 4-17. Ddi1UBL mutants design. Three mutations were made to resemble α-
helix in Ub: Ddi1UBL_S, Ddi1UBL_SK and Ddi1UBL_KSK. 
 
It was important to design mutations in such a way that they keep the proper fold 
but will introduce amino acids with different types of side chains that will not allow 
hydrophobic interactions. Since Ddi1UBL has the same fold as Ub, α-helix sequence of 
Ub was used as a template for mutations, which should ensure that mutants will still 
have the α-helix, but with different properties. All of the designed mutants expressed 
and were purified. All of them, with exception of Ddi1UBL_KSK, showed well-







Figure 4-18. 1H-15N SOFAST-HMQC spectra of Ddi1UBL_WT and its mutants. 
(a) Ddi1UBL_WT, (b) Ddi1UBL_S and (c) Ddi1UBL_SK are in 20mM NaP buffer 
at pH=6.8 and in 3mM TCEP; (d) Ddi1UBL_KSK  mutant is in the 20mM NaP 









Moreover, positions of the signals in the spectra of Ddi1UBL_S and 
Ddi1UBL_SK match positions of the signals in the Ddi1UBL WT spectrum, assuring 
that the structures of these two Ddi1UBL mutants were not affected upon substitution of 
amino acids (Figure 4-19).  
 
 
Figure 4-19. Overlay of the spectra of Ddi1UBL_WT, Ddi1UBL_S and 
Ddi1UBL_SK. All proteins were in 20mM NaP buffer at pH=6.8 with 3mM TCEP. 
Ddi1UBL_WT is shown as red peaks, Ddi1UBL_S in blue and Ddi1UBL_SK peaks 







The Ddi1UBL_KSK mutant showed very low stability during sample 
purification and preparation. It also precipitates from the 20mM sodium phosphate 
(NaP) buffer at pH 6.8. A number of buffering conditions were tested and some 
solubility was achieved in PBS at pH=7.4. Change of the pH from 7.4 to 6.8 did not 
affect the protein, therefore the amount of salt was further optimized. Finally, 20mM 
NaP buffer at pH=6.8 but in the presence of 50mM NaCl was chosen as the optimal 
conditions that ensured  protein solubility and were as close as possible to buffering 
conditions used for all other studies. There were few spectral differences for the 
Ddi1UBL_KSK in PBS and in 20mM NaP buffer with 50mM NaCl (Figure 4-20 a-c). 
Such low stability is probably caused by the fact that the mutated Ile amino acid is used 
to ensure a UBL like fold and anchors the α-helix against its β-sheet. Introducing a 
longer and charged amino acid instead of it probably made the protein less stable. The 
significant amount of signals clustered in the middle of the spectrum is indicative of the 
presence of unfolded polypeptides. Only small portions of signals with lower intensities 
are spread in the spectrum. The final question was whether Ddi1UBL_KSK had some 
structured and unstructured elements within the same polypeptide chain, or if some part 
of the sample was unfolded and only some small percentage was folded. A hetNOE 
experiment helped filter some of the signals (Figure 4-20d). Positive intensity signals 
are well dispersed all over spectrum and only negative signals are clustered in the 
middle. Moreover, the number of positive signals and their position indicate that it is 







Figure 4-20. Spectra of Ddi1UBL_KSK mutant. (a) 1H-15N SOFAST-HMQC 
Ddi1UBL_KSK in 20mM NaP buffer in the presence of 50mM NaCl at pH 6.8 with 
3mM TCEP. (b) 1H-15N SOFAST-HMQC Ddi1UBL_KSK in PBS buffer in the 
presence of 5mM DTT at pH 7.4. (c) Overlay of the spectra and two different 
buffers: 20mM NaP, 50mM NaCl, 3mM TCEP at pH 6.8 in red and PBS with 
5mM DTT at pH 7.4 in blue. (d) HetNOE spectrum of Ddi1UBL_KSK; red peaks 





4.7 Effects of mutations on binding to Ub, Dsk2UBL, K48-Ub2 and 
K63-Ub2 
Firstly, it was important to determine whether the introduced mutations affected 
the general properties of recognizing binding partners. Since the proteins were mutated 
on the α-helix site of the structure any changes should not affect recognition of Ub 
which interacts through the β-sheet. To confirm that this binding site is still active, we 
tested interactions of Ddi1UBL_SK and Ddi1UBL_KSK with Ub. Indeed when spectra 
of both samples were collected in the presence of Ub at 1:1 molar ratio and compared to 
spectra of each of the proteins alone, a number of peaks had shifted indicating that 
regardless of mutations, both constructs still interact with Ub (Figure 4-21). Following 
chemical shifts perturbation was very complicated for Ddi1UBL_KSK mutant, 
however, when such analysis was performed for the Ddi1UBL_SK mutant it can be 
easily noticed that the same residues are involved in binding as for the Ddi1UBL WT 
(Figure 4-22). Moreover, the general pattern and distribution of CSP along the sequence 
are very similar, what means that both WT and Ddi1UBL_SK recognize the ligand in 





Figure 4-21. Ddi1UBL_SK and Ddi1UBL_KSK binding to mono Ub. Top, overlay 
of the spectrum of 150µM Dd1UBL_SK (red) and in the presence of Ub mixed at 






Figure 4-22. Chemical shift perturbations of Ddi1UBL WT and Ddi1UBL_SK 
binding to Ub. Ddi1UBL WT and Ddi1UBL_SK are in 1:1 ratio with Ub. Gray 
bars show Ddi1UBL_SK  signals that attenuated upon Ub binding. Stars indicate 
residues for which data interpretation was impossible due to peak overlapping. 
Stars are colored in the same manner as in the legend. 
 
Despite the complicated nature of the Ddi1UBL_KSK spectra for detailed 
interpretation, a portion of this sample that was properly folded was still capable of Ub 
recognition. Unfortunately, the unfolded part of Ddi1UBL_KSK, did not fold upon Ub 
binding, since in the hetNOE experiment there are still a number of signals with 





Figure 4-23. HetNOE spectrum of 15N-Ddi1UBL_KSK mutant in the presence of 
Ub. Both proteins are at 1:1 molar ratio. Red peaks show positive intensities, green 
peaks show negative intensities. 
 
Furthermore, we wanted to test how the mutations affect recognition of the 
Dsk2UBL domain. Binding was again monitored by NMR and spectra were collected 
when both mutant and ligand where at 1:1 stoichiometry. Each mutant was capable of 
recognizing the ligand (Figure 4-24). It seems that the changes in the spectrum of 
Ddi1UBL_SK are smaller than in the case of Ddi1UBL_S (Figure 4-24 a-b). As for 
Ddi1UBL_KSK, the signals of structured elements upon binding could not be observed 
as already weak signals could become broaden upon binding and as a consequence 
disappear from the spectrum (Figure 24c). Unfortunately, nothing about the strength of 








Figure 4-24. Ddi1UBL mutants binding to Dsk2UBL. (a) 1H-15N SOFAST-HMQC 
of 250µM 15N-Ddi1UBL_S alone (red) and in the presence of Dsk2UBL at 1:1 ratio 
(blue). (b) Overlay of the spectrum of 250µM 15N-Ddi1UBL_SK (red) and 15N-
Ddi1UBL_SK bound to Dsk2UBL also at 1:1 ratio (blue). (c) 250µM 15N-
Ddi1UBL_KSK (red) binding to UBL domain of Dsk2 (blue) also at 1:1 ratio. (d) 
HetNOE spectrum of Ddi1UBL_KSK in the presence of Dsk2UBL at ratio 1:1; red 





The goal of the designed mutations was to affect one of potential binding sites 
that involve the α-helix. To determine if this was achieved the chemical shift 
perturbations of Ddi1UBL_WT and Ddi1UBL mutants in the presence of Dsk2UBL 
were compared (Figure 4-25). The single mutation in Ddi1UBL did affect the 
recognition of Dsk2UBL; however, there are still perturbations present in the α-helix of 
Ddi1UBL indicating that the second binding site was not fully diminished (Figure 4-
25a). 
In contrast, the Ddi1UBL_SK mutant in a similar way as wild type, bound 
through the amino acids that were part of the β-sheet site, the first binding site (Figure 
25b). Interestingly, the amino acids preceding the α-helix and the α-helix itself showed 
significantly lower chemical shift perturbations, proving that double mutation changing 
amino acids from hydrophobic to polar and charged changed the recognition of the 
ligand through a potential second binding site.  
Finally, the most promising mutation Ddi1UBL_SK was used to test binding 
properties to Ub2. Based on the spectra analysis there are still differences between K48-






















 Ddi1UBL WT+Dsk2UBL (ratio 1:1)
 Ddi1UBL SK+Dsk2UBL (ratio 1:1)
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 Ddi1UBL WT+Dsk2UBL (ratio 1:1)
 Ddi1UBL S+Dsk2UBL (ratio 1:1)
 
Figure 4-25. Comparison of chemical shift perturbations of Ddi1UBL_WT and 
Ddi1UBL mutants in the presence of Dsk2UBL. (a) CSP quantification of 
Ddi1UBL_S binding to Dsk2UBL at 1:1 ration. (b) CSP plots for Ddi1UBL_SK 






Figure 4-26. Ddi1UBL_SK binding to K48-Ub2 and K63-Ub2. Spectra of 250µM 
15N-Ddi1UBL_SK only are shown in red in both figures. Top, spectrum of 15N-
Ddi1UBL_SK in the presence of K48-Ub2 at 1:1 ratio (blue). Bottom, spectrum of 




Despite the presence of introduced mutations in Ddi1UBL, K48-Ub2 was still 
binding slightly different than mono Ub (Figure 4-27). The overall pattern of CSP 
differs for both ligands (Figure 4-28a). Moreover, more peaks attenuated in the 
spectrum of Ddi1UBL_SK upon K48-Ub2 than for Ub. Then again, K63-Ub2 was bound 
in almost the same manner as mono Ub. The CSPs are almost the same for both Ub and 
K63-Ub2 binding to Ddi1UBL_SK. The small discrepancy that can be observed is that 
K63-Ub2 has extra attenuation and few stronger CSPs (Figure 4-27 and 4-28b).  
Different K48-Ub2 and K63-Ub2 binding to Ddi1UBL_SK might indicate that 
the introduced mutations did not fully affect the second binding site, though the 
differences are smaller than for Ddi1UBL_WT binding. The second possibility is that 
K48-Ub2 in general causes slightly different changes in the chemical surrounding of the 
amide groups of Ddi1UBL than K63-Ub2 does, and even diminishing the second 
binding site still results in spectrum of the bound state that will differ than spectrum 





Figure 4-27. Comparison of Ddi1UBL_SK binding to Ub, K48-Ub2 and K63-Ub2. 
On top, comparison of bound states of Ddi1UBL_SK in the presence of monoUb 
(red) and in the presence of K48-Ub2(blue). Both bound states are at the same 
ration, 1:1. On bottom, similar type of comparison, Ddi1UBL_SK:monoUb 
spectrum at 1:1 ratio (red) is overlaid with spectrum of Ddi1UBL_SK bound to 






Figure 4-28. CSP between free Ddi1UBL_SK and Ddi1UBL_SK bound to Ub, 
K48- and K63-Ub2. (a) Comparison of CSP of Ddi1UBL_SK upon Ub binding and 
CSP of Ddi1UBL_SK upon K48-Ub2 binding. (b) Similar comparison, as in a) but 
K63-Ub2 was used as second ligand.  All compared bound states are in 1:1 molar 
ratio of Ddi1UBL_SK to its ligand. Gray bars show residues that attenuated upon 
Ub binding. Purple bars indicate residues that attenuated upon adequate Ub2 







It must be emphasized that despite potential small discrepancies in recognition 
of both Ub2 the bound states (Ddi1UBL_SK:K48-Ub2 and Ddi1UBL_SK:K63-Ub2) 
when compared with each other show very similar peak positions for the number of 
residues (Figure 4-29). This would mean that at least these peaks are affected by 
recognition of Ub2s in a very similar way.  
 
 
Figure 4-29.Comparison of Ddi1UBL_SK spectra at bound states with K48-Ub2 
and K63-Ub2. In red 15N-Ddi1UBL_SK in the presence of K48-Ub2 at 1:1 ratio, as 





Chapter 5. UBL domain of Ubp6, purification and 
NMR data collection 
Ubp6 is one of four deubiquitinase enzymes (DUB) in S.cerevisiae that 
associates with the base of the proteasome87,88. It is responsible for removing ubiquitin 
moieties from polyUb chains that are attached to the substrate protein targeted for 
degradation. It was proposed that Ubp6 is responsible for regulation of the nature and 
magnitude of proteasome activity89. Ubp6 is a cysteine protease whose activity 
increases 300-fold when bound to the proteasome87. It was shown that Ubp6 recognizes 
the proteasome’s Rpn1 subunit through its UBL domain, what makes it a very 
interesting subject for biochemistry and biophysical studies.  
5.1 Ubp6 construct design 
The construct of Ubp6UBL that was available for structural studies did not have 





For the convenience of further studies it was desired to clone this coding 
sequence in the pET15b plasmid, which contains N-terminal His-tag followed by a 
thrombin site. The pET15b plasmid was cut with NdeI and BamHI restriction enzymes. 
The same restriction sites were introduced into the primers used for the amplification of 








5.2  Protein purification 
Ubp6UBL coding sequence was cloned in pET15b vector and expressed in 
BL21(DE3) cells. The cells were grown in LB media till A600=0.6-0.8 and protein 
expression was induced with 1mM IPTG overnight at 20oC. Uniformly isotope labeled 
15N and 13C/15N Ubp6UBL protein was enriched with 15NHCl and 13C6-D-glucose (for 
double labeled sample) and grown in M9 minimal medium, and similar to the unlabeled 
sample cells, were induced overnight at 20oC. Proteins were purified using a 5mL 
HiTrap Chelating HP Column. The chromatogram and corresponding SDS-PAGE gel 
from HiTrap purification of unlabeled Ubp6UBL is shown in Figure 5-1 a) and b). 
Protein eluted from the HiTrap column was dialyzed in PBS. The His-tag was 
cleaved by incubation with thrombin for 4 hours at room temperature.  In the next step, 
the sample was passed through a 1mL benzamidine column. For the final purification 
the Ubp6UBL sample was applied to a Superdex 75 120mL column. The chromatogram 
and SDS-PAGE gel of the final sample is shown in Figure 5-1 c) and d). 
Comments: The protein sample has a tendency to precipitate at high 
concentrations. Is recommend to mix the sample often during concentrations and buffer 







Figure 5-1. Purification of unlabeled sample of Ubp6UBL. (a) Chromatogram of 
sample purification on 5mL HiTrap Chelating HP Column. (b) 15% SDS-PAGE 
gel of HiTrap Chelating HP Column purification step of unlabeled Ubp6UBL, lane 
1: lysate loaded into the column, lane2: column loading flow through, lane 3: NEB 
Protein Marker, Broad Range (2-212 kDa), lane 4-10:  HiTrap fractions M4, M13, 
M14, M15, N15, N14 and N13, respectively. (c) Chromatogram of final purification 
step of Ubp6UBL on Superdex 75 with 120mL column volume. (d) 15% SDS-
PAGE gel of unlabeled Ubp6UBL after all purification steps. Lane 1: NEB Protein 






5.3 Ubp6UBL NMR data collection for resonance assignment 
After purifying the new Ubp6UBL construct, the goal was to collect all spectra 
necessary for full resonance assignment of the UBL domain. In the future, as was done 
for Ddi1UBL, such assignment will be used to do sequential assignment which is very 
convenient for functional and structural studies. For that purpose, a series of NMR two 
and three dimensional experiments were collected with use of 15N-Ubp6UBL and 
13C,15N-Ubp6UBL samples. The following experiments were collected: HNCO, 
HN(CA)CO, HN(CO)CA, HNCA, CBCA(CO)NH, HNCACB, HNCACO as well as 
2D, 3D TOCSY and 2D, 3D  NOESY. 
5.4 Ubp6UBL has more than one conformation? 
After close examination of the 1H-15N HSQC spectrum of Ubp6UBL, it was 
interesting to note that there are more peaks in the spectrum than one would anticipate 
(Figure 5-2). For the 80 amino acid construct with 5 prolines in its sequence and 
excluding the first amino acid for which the amide is very often not observed, there 
should be 74 resonances, excluding side chains. Surprisingly, there are at least 94 peaks 
in the spectrum, counting only peaks of strong intensities but excluding peaks that 
probably come from NH2 in the side chains. The increased number of peaks in the 
spectrum can be explained either by the presence of more than one species in the 
spectrum, or that Ubp6UBL can have more than one conformation in solution. 
Ubp6UBL samples go through an extensive purification including specific affinity tag 
purification; therefore it is less probable that there will be an impurity with the same 






Figure 5-2. 1H-15N-HSQC spectrum of Ubp6UBL in 20mM phosphate buffer, 
pH=6.8, at 25oC. 
 
Another possibility is that Ubp6UBL degrades with time into small peptides. It 
would be expected that such shorter fragments will be less structured and probably 
would gain some flexibility.  
Interestingly, when the hetNOE spectrum was collected, the majority of peaks 
had positive signals indicating that they belonged to well-structured residues, and only a 






Figure 5-3. HetNOE spectrum of Ubp6UBL. In red peak with positive signal 
intensities, in green peaks with negative intensities. Spectrum collected at 25oC 
temperature. 
 
Since the majority of signals in hetNOE are positive, this would not support the 
scenario that Ubp6UBL undergoes degradation resulting in a number of smaller, less 
structured peptides. If indeed the increased number of peaks is an indication of different 
conformations of amino acids in Ubp6UBL these peaks could undergo chemical 
exchange, which is temperature dependent. When the Ubp6UBL sample spectrum was 
measured at additional temperatures 17OC and 35OC, changes in the spectrum are 
observed (Figure 5-4). As highlighted on the spectrum, two types of changes can be 
easily noticed, one, when at low temperature there is only one signal but there are two 
peaks at higher temperature, and two, when the intensities between the two peaks, 




temperature. Both phenomena are characteristic for chemical exchange when the 
nucleus exchanges intramolecularly between conformers, supporting the hypothesis that 
Ubp6UBL has more than one conformation in solution. It is worth mentioning that for 
some signals in triple resonance experiments two sets of carbon chemical shifts can be 
also observed.    
In the future, resonance and sequential assignment must be performed. The 







Figure 5-4. 1H-15N SOFAST-HMQC spectra of Ubp6UBL sample collected at low 
temperature, 17OC and higher temperature 35OC. The highlighted ellipsoids 








Chapter 6. Discussion and future project direction 
6.1 Discussion  
This work presents a thorough characterization of Ddi1 from S.cerevisiae and 
provides important information about its potential function in the cell. The UBL domain 
is capable of recognizing Ub and Ub conjugates, shedding new light on this system, and 
is important in explaining how a protein without a UBA domain can perform its 
shuttling function. 
Ddi1 is a multi-domain protein in which each domain performs a different 
function. All three main domains: UBL, RVP and UBA do not interact with each other 
and are connected through flexible linkers that allow them to tumble independently. 
This finding justifies the relevance of structural and functional studies of UBA and 
UBL domains individually. Despite low sequence identities the N-terminal fragment of 
Ddi1 has a ubiquitin-like fold. There are small discrepancies between this structure and 
the structure of Ub, such as secondary structure packing, the presence of a long flexible 
loop, and lack of a classical Ub hydrophobic patch. Surprisingly, the UBL domain of 
Ddi1 displayed completely unexpected binding properties. Based on our knowledge, the 
Ddi1UBL domain is the first UBL domain that has a ubiquitin-like fold but does not 
behave as ubiquitin with respect to its binding preferences. Here, it was shown that the 
UBL domain of Ddi1 is capable of interacting with Ub itself which is unusual and has 
not been observed for any other UBL domain before. Ddi1UBL utilizes the binding site 
that is located on the β-sheet, similar to the one on Ub. The interface between these two 




charged residues. Interestingly, this interaction is stronger than the UBA interaction 
with ubiquitin. The unique features of Ddi1 UBL discovered in this work allows for re-
interpretation of some published data. The fluorescence studies published by Bertolaet 
et al., 2001 show that full-length Ddi1 interacts with Ub with an Kd of ~10 µM. Based 
on the results presented here, it can be concluded that the main source of strong binding 
was the Ub:Ddi1UBL interaction and not the Ub:Ddi1UBA interaction, as previously 
interpreted32.   
In addition to the Ddi1UBL interaction with Ub, these studies show that it can 
also interact with the UBL domain of Dsk2. Unfortunately, the implications of this 
interaction for the function of Ddi1 are unclear. Nevertheless, this interaction involves 
two binding sites on the Ddi1UBL structure. One, β-sheet which is the same as for Ub 
binding, and another that includes the α-helix with a UIM-like motif, which is again 
unique for the Ddi1 when compared to known UBL domains. Also, the second binding 
site discovered in this work helps the UBL domain of Ddi1 to distinguish between 
different Ub2 linkages, which might be very important for selecting the proper linkage 
when performing the shuttling function.  
It was shown in previous studies that turnover of the Ufo1 protein depends upon 
Ddi156. Knowing that the presence of the UBL domain of Ddi1 and UIMs of Ufo1 is 
important for this phenomenon, we tested whether both domains interact with each 
other. Surprisingly, no direct interaction was observed between them. However, based 
on the unique properties of the Ddi1 UBL domain, such as selecting for polyUb chains 
and that UIMs of Ufo1 binds Ub, it can be proposed that the Ufo1:Ddi1 interaction is 




important for degradation of Ho endonuclease, and both proteins interact only while Ho 
endonuclease is already ubiquitinated, Ddi1 might interact with the Ub chain on Ho 
endonuclease not only through UBA but also through the UBL domain90.  Since Ho 
endonuclease is recruited by Ufo1 to the SCF complex for ubiquitination, it is possible 
that (1) the UIM domains of Ufo1 stabilize ubiquitin chain build up on the substrate and 
once the chain has reached the appropriate length for signal degradation, the UBL 
domain of Ddi1 outcompetes the Ufo1UIM:Ub interaction with its stronger affinity and 
helps in releasing the ubiquitinated Ho endonuclease from the E3 ligase, (2) in a 
situation where Ufo1 is not near Ho endonuclease in space, the Ufo1:Ub:Ddi1 complex  
aids in bringing Ddi1 in close proximity to ubiquitinated Ho endonuclease, hence 
allowing the UBA domain of Ddi1 to reach the Ub chain on the substrate, and (3) 
despite Ufo1 and Ho endonuclease being functionally linked, their interactions with 
Ddi1 are independent processes. 
Nevertheless, as a shuttle protein Ddi1 should bind ubiquitinated proteins and 
deliver them to the proteasome for degradation. For Ddi1 in S.cerevisiae, a number of 
possible modes of interaction with polyUb chains can be proposed (Figure 7-1). 
“Classical” UBL-UBA shuttle proteins (Rad23, Dsk2) utilize their UBA domain(s) to 
bind to the polyUb tag on a substrate, and use their UBL domain to bind to the Rpn1 
subunit of the 19S regulatory particle (RP)82,91. The unusual dual functionality of the 
Ddi1 UBL, which is capable of binding both Ub and 19S RP, suggests that Ddi1 might 
not act as a classical shuttle protein. Both UBL and UBA of Ddi1 could be bound to 
polyUb (Figure 7-2), with subsequent dissociation of the UBL to bind to Rpn1 when in 




Rad23 through the UBA1 and acts as a tandem shuttle. It should be kept in mind that 
the same heterodimerization will increase the local concentration of the Ub-binding 
domains and protect the chain together with UBA2 domains of Rad23. Consequently, 
depending on the interaction Ddi1 is involved in, it will act either as a positive or 
negative regulator, delivering for degradation and consequently disassembling the 
polyUb chains or protecting the chains from degradation.  
 
 
Figure 6-1. Ddi1 recognition of ubiquitinated substrates in S.cerevisiae. Ddi1 has 
two domains UBA and UBL, that can recognize Ub, therefore it can use either or 







Figure 6-2. Schematic representation of a possible function of Ddi1 as a 





To summarize, the detailed role of Ddi1 and its unique UBL domain is not fully 
understood. UBL domain binding to Ub indicates that Ddi1 might not be a classical 
shuttle protein. Moreover, other UBL-UBA proteins have both UBA and UBL domains 
conserved among different eukaryotes while Ddi1 retains its UBL domain in higher 
eukaryotes but does not have a UBA domain any longer. This evolution any change 
might be added proof that Ddi1 performs its shuttle protein role differently than Rad23 
and Dsk2. Finally, more studies need to be performed to fully understand the detailed 
function of the UBL domain of Ddi1 in the cell. Based on these findings, it will be 
required to redefine what it means for a domain to be ubiquitin-like.  
 
6.2 Future project direction 
The presented research introduced significant insights into the role of Ddi1; 
however it is not clear how in detail Ddi1 performs its function. First, it is not fully 
understood how Ddi1 is recognized by the proteasome. There were two studies that 
examined the Ddi1 interaction with proteasomal Rpn1 subunit; however they delivered 
contradictory results20,91. Therefore, further studies should focus on characterizing 
whether and how Ddi1 interacts with the proteasome. There are four main subunits that 
are potential docking sites for the Ddi1 as a shuttle: Rpn1, Rpn2, Rpn10 and Rpn13 and 
it is necessary to examine whether Ddi1 interacts with any of them. More interestingly, 
if any of these interactions are mediated through the UBL domain, it will be necessary 
to compare it with binding of already characterized partners and consequently try to 




Competition experiments would definitely deliver more information about such a 
possibility. Additionally, it will be fascinating to see if Ddi1 is capable of pulling any 
component of the proteasome from the cell extract. This would provide further evidence 
that Ddi1 is involved in the ubiquitin proteasomal system. 
It must be emphasized that the above results were conducted with Ddi1 from 
S.cerevisiae. The same properties should be tested with constructs from other 
organisms, especially the UBL domain in Ddi1 from mammals. This is very important 
to keep in mind that the UBA domain is not present in mammals (Figure 1-16), therefor 
it would be essential for the Ddi1UBL domain from these organisms to also have Ub 
binding capability in order to perform Ddi1 shuttling function.  
Finally, there are some discrepancies between the UBL domain in yeast and in 




Figure 6-3. Sequence alignment of UBL domain of Ddi1 from S.cerevisiae and from 
H.sapiens. Lines indicate identity between sequences; colons indicate similarity. 
Underlined is the UIM like sequence in Ddi1UBL from S.cerevisiae. The EMBOSS 






Based on Emboss alignment results, both UBL sequences share approximately 
40% similarity. Interestingly, the LIALL sequence that is present in Ddi1UBL from 
S.cerevisiae is not present in the Ddi1 UBL domain in H.sapiens. This questions 
whether human Ddi1UBL will have the same binding properties, especially for 
Dsk2UBL and Ub2. 
Ddi1 and particularly its UBL domain are very interesting subjects to study and 
clearly it is very important to understand its function and involvement in the ubiquitin 
proteasomal system. Future studies will help to answer the question of whether 







Chapter 7. Materials and methods 
7.1 Proteins constructs and purifications 
The Ddi1UBL construct used in these studies contains the UBL domain of yeast 
Ddi1 amino acids 2-80 (Uniprot P40087), 12 amino acids at the N-terminus with a His-
tag (MRGSHHHHHHGS) and 3 amino acids at the C-terminal (KLN). Since both 
extensions are not part of Ddi1 all amino acid numbering presented in the paper 
corresponds to the actual residue position in Ddi1. Ddi1UBL mutants, Ddi1FL, 
Dsk2FL, Rad23FL, Dsk2UBL, Rad23UBL and Ufo1UIM (Uniprot Q04511, 576-668 
fragment containing three UIM motifs) constructs also contain His-tag extension for 
purification purpose. They were cloned in the pQE30 vector (Qiagen) and expressed in 
M15 cells, with the exception of Ufo1UIM which was cloned in pET28b (Novagen) and 
expressed in BL21(DE3)-Rosetta cells, and Ub which was in pET3a and expressed from 
BL21(DE3)-pJY2 cells.  All above constructs were grown in LB media till A600=0.6-0.8 
and induced with 1mM IPTG for 6h at 37oC, or overnight at 20oC. Isotopically labeled 
15N or 13C/15N Ddi1UBL was uniformly enriched with 15NH4Cl or 13C6-D-glucose in 
M9 minimal medium and induced overnight at 20oC. Proteins were purified using 5mL 
HiTrap Chelating HP Column followed by size exclusion separation on a Superdex 75 
120mL column. Expression and purification of human Ub WT was performed as 




7.2 Sequence analysis  
All sequences used for analysis of the Ddi1 gene structure can be found in the 
Uniprot Database under the following ID numbers: Q8WTU0, Q95JI3, Q9DAF3, 
A0JPP7, F1MG01, A8B333, B9SX98, B9QR20, Q4UDI9, Q10256, Q5AY89, G3JEF4, 
Q2H085 and Q54JB0. Sequence comparison was performed using 
ClustalW/ClustalOmega software available at EMBL-EBI webpage and domain 
prediction software CDD and SMART93-98. Sequence alignment  and quantification of 
sequence identity and similarity of Ddi1 UBA and UBL domains with human Ub 
(P0CG47), yeast Ub (P0CG63), Dsk2 (P48510), Rad23 (P32628) was performed using 
EMBOSS software60. Sequence comparison of α-helix of Ddi1UBL with known UIM 
domains was also done with ClustalOmega94,95. Uniprot codes of sequences used for 
this comparison: P42567, Q12518, P55036, P38886, Q9UHP3, P40343, Q8GY23 and 
O14964. 
7.3 NMR experiments 
Final NMR samples were prepared in 20mM sodium phosphate buffer, pH 6.8, 
5% D2O, 0.02% NaN3. In addition Ddi1FL, Ddi1UBL, Rad23UBL samples and Cys 
mutants of Ub contained 3mM TCEP. All measurements were collected on Avance III 
600 MHz Brucker Biospin spectrometer equipped with CPTCI cryoprobe and on 
800MHz Brucker Ascend equipped with CPQCI cryoprobe at 23oC. All spectra were 
processed using TopSpin 2.1 software and were analyzed using Sparky or CARA 
programs66,99,100. 1H-15N HSQC and TROSY spectra were acquired for verification of 




HNCO, HN(CA)CO, HN(CO)CA, HNCA, CBCA(CO)NH, HNCACB were used for 
1HN, 15N, C’, Cα, Cβ resonance assignment. CC(CO)NH, H(CCO)HN along with 2D and 
3D TOCSY were used to obtain complete proton and carbon Ddi1UBL assignment. 2D 
and 3D NOESY spectra were collected and analyzed to obtain inter-proton NOE 
distance constraints for Ddi1UBL. 15N relaxation measurements: T1, T2 and steady-
state hNOE were performed as described previously101. The overall rotational 
correlation time (τc) was determined using ROTDIF79,101. The RDC measurements were 
performed in PEG/hexanol-based alignment medium102 using IPAP-HSQC 
experiments73 and analysed using ALTENS program to determine alignment tensors41.  
7.4 NMR binding assays 
All binding experiments were conducted by monitoring changes in the peak 
positions in 1H-15N SOFAST-HMQC spectra upon titrations, with the exception of 
Ddi1FL for which 1H-15N TROSY experiments were collected. The changes in peak 
positions were quantified as chemical shift perturbations (CSP) using the following 
equation ∆δ=[ ∆δΗ2 + (∆δΝ/5)2]0.5, where  and  are difference in the chemical 
shift for 1H and 15N respectively. Obtained CSP values were used to calculate the 
binding affinities by fitting different binding models using in-house software KDfit as 
detailed eslewhere41.  
7.5 HD exchange experiments 
1mM sample of 15N Ddi1UBL was lyophilized in 20mM sodium phosphate 




experiments. A series of 1H-15N SOFAST-HMQC spectra were collected at 600MHz 
Bruker spectrometer at 23oC. All experiments were collected with the same 
experimental parameters with the exception of the number of scans. In total 45 spectra 
were collected over a time of ~4h, experiments 1 to 14 were collected with 4 scans and 
approximate experimental time of each was 2.5 minutes, 15 to 34 had 8 scans and every 
experiment took 5 min, in the last series 35-45 each experiment had 16 scans and took 
10 min. The dead time between sample resuspension in D2O and first experiment was 8 
min. It was assumed that buffering properties are very similar in H2O and D2O, and no 
major shifts will be observed in the spectrum. This hypothesis was confirmed after 
collecting spectra. 
7.6 PRE experiments for complex structure calculations  
The paramagnetic spin label, 1-oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl 
methanesulfonate (MTSL), was attached to a Cys side chain of each of the constructs: 
UbT12C, UbK63C and UbG75Cs, as described41,103. The paramagnetic relaxation 
enhancement (PRE) effects in Ddi1UBL were expressed for each amino acids as the 
ratio of the signal intensities in the 1H-15N HSQC spectra recorded with MTSL in the 
oxidized and reduced states. All measurements were performed for 15N-Ddi1UBL 
mixed in 1:1 molar ratio with UbT12C-MTSL, UbK63C-MTSL or UbG75C-MTSL. 
PRE data analysis such as reconstruction of the MTSL position on Ub and distance 
between spin label and particular amino acid position was determined with a use of 




7.7 Ddi1FL DUB activity assay 
Reaction mixture contained 25 µM of a given di-ubiquitin chain (K6-, K11-, 
K27-, K29-, K33-, K48-, K63-Ub2) and 5 µM of FL Ddi1, in 50 mM Tris at pH 8.0. 
Total reaction volume was 50µL and each reaction was carried out at 30oC. Samples 
were taken at indicated time points, ran on SDS-PAGE gels, and stained with coomassie 
blue. 
7.8 Sedimentation equilibrium 
The molecular mass of Ddi1UBL was determined by sedimentation equilibrium 
measurement using Beckman Coulter Optima XL-1 instrument. The analytical 
ultracentrifuge was equipped with a four-hole An-60 rotor. The sample was placed in 
12mm six-hole cells with charcoal-filled Epon centerpieces with sapphire windows. 
Ddi1UBL (250µM) sample in 20mM sodium phosphate buffer, pH 6.8 with 3mM 
TCEP was centrifuged at three rotor speeds: 26000, 29000 and 32000 rpm at 20oC.  
Absorbance at 290nm was measured with 0.001 cm intervals and 5 replicates per step. 
All data were analyzed globally using the program WinNonLin105. The best fit was 
obtained for the single species model.  The reduced molecular weight (σ) obtained from 
this analysis allowed for the calculation of the molecular weight (M): 
σ = ((M(1-υρ)) / RT)ω2 
υ is partial specific volume of the protein, ρ is buffer density, ω is rotor angular 




7.9 Mass spectrometry 
The mass spectra of the diluted sample of Ddi1UBL were collected using 
electrospray positive mode with flow injection on JEOL AccuTOF-CS mass 
spectrometer and were deconvoluted using MagTran software. 
7.10 Circular dichroism 
The spectra were measured in Jasco J-810 spectropolarimeter in continuous 
mode with 100nm/min scanning speed, 4sec response and 2nm bandwidth. The 
experiments were performed at 4.5µM Ufo1UIM concentration in 20mM NaP buffer at 
pH 6.8 in a cuvette with 10mm path length. Ellipticity was monitored in the range of 







1. Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21 
(1994). 
 
2. Yamaguchi, R. & Dutta, A. Proteasome inhibitors alter the orderly progression 
of DNA synthesis during S-phase in HeLa cells and lead to rereplication of 
DNA. Exp Cell Res 261, 271-83 (2000). 
 
3. Conaway, R.C., Brower, C.S. & Conaway, J.W. Emerging roles of ubiquitin in 
transcription regulation. Science 296, 1254-8 (2002). 
 
4. Muratani, M. & Tansey, W.P. How the ubiquitin-proteasome system controls 
transcription. Nat Rev Mol Cell Biol 4, 192-201 (2003). 
 
5. Schubert, U. et al. Rapid degradation of a large fraction of newly synthesized 
proteins by proteasomes. Nature 404, 770-4 (2000). 
 
6. Rock, K.L. & Goldberg, A.L. Degradation of cell proteins and the generation of 
MHC class I-presented peptides. Annu Rev Immunol 17, 739-79 (1999). 
 
7. Hicke, L. A new ticket for entry into budding vesicles-ubiquitin. Cell 106, 527-
30 (2001). 
 
8. Hicke, L. Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2, 195-
201 (2001). 
 
9. Hoege, C., Pfander, B., Moldovan, G.L., Pyrowolakis, G. & Jentsch, S. RAD6-
dependent DNA repair is linked to modification of PCNA by ubiquitin and 
SUMO. Nature 419, 135-41 (2002). 
 
10. Spence, J., Sadis, S., Haas, A.L. & Finley, D. A ubiquitin mutant with specific 
defects in DNA repair and multiubiquitination. Mol Cell Biol 15, 1265-73 
(1995). 
 
11. Ciechanover, A. The ubiquitin-mediated proteolytic pathway: mechanisms of 
action and cellular physiology. Biol Chem Hoppe Seyler 375, 565-81 (1994). 
 
12. Lee, D.H. & Goldberg, A.L. Proteasome inhibitors: valuable new tools for cell 





13. Rock, K.L. et al. Inhibitors of the proteasome block the degradation of most cell 
proteins and the generation of peptides presented on MHC class I molecules. 
Cell 78, 761-71 (1994). 
 
14. Adams, J. et al. Proteasome inhibitors: a novel class of potent and effective 
antitumor agents. Cancer Res 59, 2615-22 (1999). 
 
15. McNaught, K.S. & Olanow, C.W. Proteasome inhibitor-induced model of 
Parkinson's disease. Ann Neurol 60, 243-7 (2006). 
 
16. McNaught, K.S., Jackson, T., JnoBaptiste, R., Kapustin, A. & Olanow, C.W. 
Proteasomal dysfunction in sporadic Parkinson's disease. Neurology 66, S37-49 
(2006). 
 
17. Clarke, D.J. et al. Dosage suppressors of pds1 implicate ubiquitin-associated 
domains in checkpoint control. Molecular and Cellular Biology 21, 1997-2007 
(2001). 
 
18. Elsasser, S., Chandler-Militello, D., Müller, B., Hanna, J. & Finley, D. Rad23 
and Rpn10 serve as alternative ubiquitin receptors for the proteasome. J Biol 
Chem 279, 26817-22 (2004). 
 
19. Elsasser, S. & Finley, D. Delivery of ubiquitinated substrates to protein-
unfolding machines. Nat Cell Biol 7, 742-9 (2005). 
 
20. Gomez, T.A., Kolawa, N., Gee, M., Sweredoski, M.J. & Deshaies, R.J. 
Identification of a functional docking site in the Rpn1 LRR domain for the 
UBA-UBL domain protein Ddi1. BMC Biol 9, 33 (2011). 
 
21. Hartmann-Petersen, R. & Gordon, C. Integral UBL domain proteins: a family of 
proteasome interacting proteins. Semin Cell Dev Biol 15, 247-59 (2004). 
 
22. Hicke, L., Schubert, H.L. & Hill, C.P. Ubiquitin-binding domains. Nat Rev Mol 
Cell Biol 6, 610-21 (2005). 
 
23. Kaplun, L. et al. The DNA damage-inducible UbL-UbA protein Ddi1 
participates in Mec1-mediated degradation of Ho endonuclease. Mol Cell Biol 
25, 5355-62 (2005). 
 
24. Kleijnen, M.F. et al. The hPLIC proteins may provide a link between the 
ubiquitination machinery and the proteasome. Mol Cell 6, 409-19 (2000). 
 
25. Lambertson, D., Chen, L. & Madura, K. Pleiotropic defects caused by loss of the 
proteasome-interacting factors Rad23 and Rpn10 of Saccharomyces cerevisiae. 




26. Saeki, Y., Saitoh, A., Toh-e, A. & Yokosawa, H. Ubiquitin-like proteins and 
Rpn10 play cooperative roles in ubiquitin-dependent proteolysis. Biochem 
Biophys Res Commun 293, 986-92 (2002). 
 
27. Husnjak, K. et al. Proteasome subunit Rpn13 is a novel ubiquitin receptor. 
Nature 453, 481-8 (2008). 
 
28. Díaz-Martínez, L.A., Kang, Y., Walters, K.J. & Clarke, D.J. Yeast UBL-UBA 
proteins have partially redundant functions in cell cycle control. Cell Div 1, 28 
(2006). 
 
29. Rao, H. & Sastry, A. Recognition of specific ubiquitin conjugates is important 
for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 
and Rad23. J Biol Chem 277, 11691-5 (2002). 
 
30. Kang, Y. et al. UBL/UBA ubiquitin receptor proteins bind a common 
tetraubiquitin chain. J Mol Biol 356, 1027-35 (2006). 
 
31. Verma, R., Oania, R., Graumann, J. & Deshaies, R.J. Multiubiquitin chain 
receptors define a layer of substrate selectivity in the ubiquitin-proteasome 
system. Cell 118, 99-110 (2004). 
 
32. Bertolaet, B.L. et al. UBA domains of DNA damage-inducible proteins interact 
with ubiquitin. Nature Structural Biology 8, 417-422 (2001). 
 
33. Chen, L., Shinde, U., Ortolan, T.G. & Madura, K. Ubiquitin-associated (UBA) 
domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain 
assembly. EMBO Rep 2, 933-8 (2001). 
 
34. Funakoshi, M., Sasaki, T., Nishimoto, T. & Kobayashi, H. Budding yeast Dsk2p 
is a polyubiquitin-binding protein that can interact with the proteasome. Proc 
Natl Acad Sci U S A 99, 745-50 (2002). 
 
35. Wilkinson, C.R. et al. Proteins containing the UBA domain are able to bind to 
multi-ubiquitin chains. Nat Cell Biol 3, 939-43 (2001). 
 
36. Beal, R., Deveraux, Q., Xia, G., Rechsteiner, M. & Pickart, C. Surface 
hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. 
Proc Natl Acad Sci U S A 93, 861-6 (1996). 
 
37. Haririnia, A. et al. Mutations in the hydrophobic core of ubiquitin differentially 
affect its recognition by receptor proteins. J Mol Biol 375, 979-96 (2008). 
 
38. Sloper-Mould, K.E., Jemc, J.C., Pickart, C.M. & Hicke, L. Distinct functional 




39. Fushman, D. & Walker, O. Exploring the linkage dependence of polyubiquitin 
conformations using molecular modeling. J Mol Biol 395, 803-14 (2010). 
 
40. Varadan, R., Walker, O., Pickart, C. & Fushman, D. Structural properties of 
polyubiquitin chains in solution. J Mol Biol 324, 637-47 (2002). 
 
41. Varadan, R. et al. Solution conformation of Lys63-linked di-ubiquitin chain 
provides clues to functional diversity of polyubiquitin signaling. J Biol Chem 
279, 7055-63 (2004). 
 
42. Varadan, R., Assfalg, M., Raasi, S., Pickart, C. & Fushman, D. Structural 
determinants for selective recognition of a Lys48-linked polyubiquitin chain by 
a UBA domain. Mol Cell 18, 687-98 (2005). 
 
43. Glickman, M.H. & Ciechanover, A. The ubiquitin-proteasome proteolytic 
pathway: destruction for the sake of construction. Physiol Rev 82, 373-428 
(2002). 
 
44. Bachmair, A. & Varshavsky, A. The degradation signal in a short-lived protein. 
Cell 56, 1019-32 (1989). 
 
45. Al-Hakim, A. et al. The ubiquitous role of ubiquitin in the DNA damage 
response. DNA Repair (Amst) 9, 1229-40 (2010). 
 
46. Kirkpatrick, D.S. et al. Quantitative analysis of in vitro ubiquitinated cyclin B1 
reveals complex chain topology. Nat Cell Biol 8, 700-10 (2006). 
 
47. Jin, L., Williamson, A., Banerjee, S., Philipp, I. & Rape, M. Mechanism of 
ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133, 
653-65 (2008). 
 
48. Deng, L. et al. Activation of the IkappaB kinase complex by TRAF6 requires a 
dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin 
chain. Cell 103, 351-61 (2000). 
 
49. Pickart, C.M. & Fushman, D. Polyubiquitin chains: polymeric protein signals. 
Curr Opin Chem Biol 8, 610-6 (2004). 
 
50. Hochstrasser, M. Lingering mysteries of ubiquitin-chain assembly. Cell 124, 27-
34 (2006). 
 
51. Thrower, J.S., Hoffman, L., Rechsteiner, M. & Pickart, C.M. Recognition of the 
polyubiquitin proteolytic signal. EMBO J 19, 94-102 (2000). 
 
52. Ciechanover, A. The ubiquitin-proteasome pathway: on protein death and cell 




53. Deffenbaugh, A.E. et al. Release of ubiquitin-charged Cdc34-S - Ub from the 
RING domain is essential for ubiquitination of the SCF(Cdc4)-bound substrate 
Sic1. Cell 114, 611-22 (2003). 
 
54. Hofmann, K. & Falquet, L. A ubiquitin-interacting motif conserved in 
components of the proteasomal and lysosomal protein degradation systems. 
Trends Biochem Sci 26, 347-50 (2001). 
 
55. Jelinsky, S.A., Estep, P., Church, G.M. & Samson, L.D. Regulatory networks 
revealed by transcriptional profiling of damaged Saccharomyces cerevisiae 
cells: Rpn4 links base excision repair with proteasomes. Mol Cell Biol 20, 8157-
67 (2000). 
 
56. Ivantsiv, Y., Kaplun, L., Tzirkin-Goldin, R., Shabek, N. & Raveh, D. Unique 
role for the UbL-UbA protein Ddi1 in turnover of SCFUfo1 complexes. Mol 
Cell Biol 26, 1579-88 (2006). 
 
57. Liu, Y.L. & Xiao, W. Bidirectional regulation of two DNA-damage-inducible 
genes, MAG1 and DDI1, from Saccharomyces cerevisiae. Molecular 
Microbiology 23, 777-789 (1997). 
 
58. Gabriely, G., Kama, R., Gelin-Licht, R. & Gerst, J.E. Different domains of the 
UBL-UBA ubiquitin receptor, Ddi1/Vsm1, are involved in its multiple cellular 
roles. Mol Biol Cell 19, 3625-37 (2008). 
 
59. Sirkis, R., Gerst, J.E. & Fass, D. Ddi1, a eukaryotic protein with the retroviral 
protease fold. Journal of Molecular Biology 364, 376-387 (2006). 
 
60. Rice, P., Longden, I. & Bleasby, A. EMBOSS: the European Molecular Biology 
Open Software Suite. Trends Genet 16, 276-7 (2000). 
 
61. Bertolaet, B.L. et al. UBA domains mediate protein-protein interactions between 
two DNA damage-inducible proteins. Journal of Molecular Biology 313, 955-
963 (2001). 
 
62. Sasaki, T., Funakoshi, M., Endicott, J.A. & Kobayashi, H. Budding yeast Dsk2 
protein forms a homodimer via its C-terminal UBA domain. Biochem Biophys 
Res Commun 336, 530-5 (2005). 
 
63. Hiyama, H. et al. Interaction of hHR23 with S5a. The ubiquitin-like domain of 
hHR23 mediates interaction with S5a subunit of 26 S proteasome. J Biol Chem 







64. Kaplun, L., Ivantsiv, Y., Kornitzer, D. & Raveh, D. Functions of the DNA 
damage response pathway target Ho endonuclease of yeast for degradation via 
the ubiquitin-26S proteasome system. Proc Natl Acad Sci U S A 97, 10077-82 
(2000). 
 
65. Kaplun, L., Ivantsiv, Y., Bakhrat, A. & Raveh, D. DNA damage response-
mediated degradation of Ho endonuclease via the ubiquitin system involves its 
nuclear export. J Biol Chem 278, 48727-34 (2003). 
 
66. Keller, R. The Computer Aided Resonances Assignment Turorial, (CANTINA 
Verlag, 2004). 
 
67. Sitkoff, D. & Case, D. Theories of chemical shift anisotropies in proteins and 
nucleic acids. Progress in Nuclear Magnetic Resonance Spectroscopy 32, 165-
190 (1998). 
 
68. Schwarzinger, S., Kroon, G.J., Foss, T.R., Wright, P.E. & Dyson, H.J. Random 
coil chemical shifts in acidic 8 M urea: implementation of random coil shift data 
in NMRView. J Biomol NMR 18, 43-8 (2000). 
 
69. Wishart, D.S. & Case, D.A. Use of chemical shifts in macromolecular structure 
determination. Methods Enzymol 338, 3-34 (2001). 
 
70. Wishart, D.S., Sykes, B.D. & Richards, F.M. The chemical shift index: a fast 
and simple method for the assignment of protein secondary structure through 
NMR spectroscopy. Biochemistry 31, 1647-51 (1992). 
 
71. Wishart, D.S. & Sykes, B.D. The 13C chemical-shift index: a simple method for 
the identification of protein secondary structure using 13C chemical-shift data. J 
Biomol NMR 4, 171-80 (1994). 
 
72. Berjanskii, M.V. & Wishart, D.S. A simple method to predict protein flexibility 
using secondary chemical shifts. J Am Chem Soc 127, 14970-1 (2005). 
 
73. Ottiger, M., Delaglio, F. & Bax, A. Measurement of J and dipolar couplings 
from simplified two-dimensional NMR spectra. J Magn Reson 131, 373-8 
(1998). 
 
74. Nilges, M., Macias, M.J., O'Donoghue, S.I. & Oschkinat, H. Automated 
NOESY interpretation with ambiguous distance restraints: the refined NMR 
solution structure of the pleckstrin homology domain from beta-spectrin. J Mol 
Biol 269, 408-22 (1997). 
 
75. Rieping, W. et al. ARIA2: automated NOE assignment and data integration in 




76. Brunger, A.T. et al. Crystallography & NMR system: A new software suite for 
macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 
54, 905-21 (1998). 
 
77. Clore, G. & Garrett, D. R-factor, free R, and complete cross-validation for 
dipolar coupling refinement of NMR structures. Journal of the American 
Chemical Society 121, 9008-9012 (1999). 
 
78. The Pymol Molecular Graphics System, Version 1.2r1. (Schrödinger, LLC.). 
 
79. Walker, O., Varadan, R. & Fushman, D. Efficient and accurate determination of 
the overall rotational diffusion tensor of a molecule from (15)N relaxation data 
using computer program ROTDIF. J Magn Reson 168, 336-45 (2004). 
 
80. Tjandra, N., Feller, S.E., Pastor, R.W. & Bax, A. Rotational diffusion anisotropy 
of human ubiquitin from 15N NMR relaxation. Journal of the American 
Chemical Society 117, 12562-12566 (1995). 
 
81. Haririnia, A., D'Onofrio, M. & Fushman, D. Mapping the interactions between 
Lys48 and Lys63-linked di-ubiquitins and a ubiquitin-interacting motif of S5a. J 
Mol Biol 368, 753-66 (2007). 
 
82. Zhang, D. et al. Together, Rpn10 and Dsk2 can serve as a polyubiquitin chain-
length sensor. Mol Cell 36, 1018-33 (2009). 
 
83. Dominguez, C., Boelens, R. & Bonvin, A.M. HADDOCK: a protein-protein 
docking approach based on biochemical or biophysical information. J Am Chem 
Soc 125, 1731-7 (2003). 
 
84. de Vries, S.J. et al. HADDOCK versus HADDOCK: new features and 
performance of HADDOCK2.0 on the CAPRI targets. Proteins 69, 726-33 
(2007). 
 
85. de Vries, S.J., van Dijk, M. & Bonvin, A.M. The HADDOCK web server for 
data-driven biomolecular docking. Nat Protoc 5, 883-97 (2010). 
 
86. Hubbard, S.J. & Thornton, J.M. NACCESS Computer Program. (Department of 
Biochemistry and Molecular Biology, University College London, 1993). 
 
87. Leggett, D.S. et al. Multiple associated proteins regulate proteasome structure 
and function. Mol Cell 10, 495-507 (2002). 
 
88. Verma, R. et al. Proteasomal proteomics: identification of nucleotide-sensitive 
proteasome-interacting proteins by mass spectrometric analysis of affinity-




89. Hanna, J. et al. Deubiquitinating enzyme Ubp6 functions noncatalytically to 
delay proteasomal degradation. Cell 127, 99-111 (2006). 
 
90. Tzirkin, R., Ivantsiv, Y., Klyman, E. & Raveh, D. The ubiquitin domain protein 
Ddi1 functions in DNA damage response mediated degradation of Ho 
endonuclease of yeast. Yeast 20, S144-S144 (2003). 
 
91. Rosenzweig, R., Bronner, V., Zhang, D., Fushman, D. & Glickman, M.H. Rpn1 
and Rpn2 coordinate ubiquitin processing factors at proteasome. J Biol Chem 
287, 14659-71 (2012). 
 
92. Zhang, D., Raasi, S. & Fushman, D. Affinity makes the difference: nonselective 
interaction of the UBA domain of Ubiquilin-1 with monomeric ubiquitin and 
polyubiquitin chains. J Mol Biol 377, 162-80 (2008). 
 
93. Goujon, M. et al. A new bioinformatics analysis tools framework at EMBL-EBI. 
Nucleic Acids Res 38, W695-9 (2010). 
 
94. Larkin, M.A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 
2947-8 (2007). 
 
95. Sievers, F. et al. Fast, scalable generation of high-quality protein multiple 
sequence alignments using Clustal Omega. Mol Syst Biol 7, 539 (2011). 
 
96. Marchler-Bauer, A. et al. CDD: conserved domains and protein three-
dimensional structure. Nucleic Acids Res 41, D348-52 (2013). 
 
97. Schultz, J., Milpetz, F., Bork, P. & Ponting, C.P. SMART, a simple modular 
architecture research tool: identification of signaling domains. Proc Natl Acad 
Sci U S A 95, 5857-64 (1998). 
 
98. Letunic, I., Doerks, T. & Bork, P. SMART 7: recent updates to the protein 
domain annotation resource. Nucleic Acids Res 40, D302-5 (2012). 
 
99. Keller, R. Optimizing the process of nuclear magnetic resonance spectrum 
analysis and computer aided resonance assignment. (Thèse de doctorat, ETH 
Zurich Thesis No. 15947 , Swit). 
 
100. Goddard, T.D. & Kneller, D.G. SPARKY 3, University of California, San 
Francisco. 
 
101. Hall, J.B. & Fushman, D. Characterization of the overall and local dynamics of a 
protein with intermediate rotational anisotropy: Differentiating between 
conformational exchange and anisotropic diffusion in the B3 domain of protein 




102. Ruckert, M. & Otting, G. Alignment of biological macromoleculse in novel 
nonionic liquid crystalline media for NMR experiments. J. Amer. Chem. Soc. 
122, 7793-7797 (2000). 
 
103. Varadan, R., Assfalg, M. & Fushman, D. Using NMR spectroscopy to monitor 
ubiquitin chain conformation and interactions with ubiquitin-binding domains. 
in Ubiquitin and Protein Degradation, Methods in Enzymology, Vol. 399 part B, 
Vol. 399 part B (ed. R.J.Deshaies) 177-192 (2005). 
 
104. Ryabov, Y. & Fushman, D. Interdomain mobility in di-ubiquitin revealed by 
NMR. Proteins 63, 787-96 (2006). 
 
105. Johnson, M.L., Correia, J.J., Yphantis, D.A. & Halvorson, H.R. Analysis of data 
from the analytical ultracentrifuge by nonlinear least-squares techniques. 
Biophys J 36, 575-88 (1981). 
 
 
151 
 
